Finex logo
Finex Intelligence

Market Signal Briefing

Wire-ready dashboard awaiting your first source connection.

Last news saved at Mar 30, 13:54 1mo ago Cron last ran Mar 30, 13:54 1mo ago Awaiting first source
Switch language
91,488 Stories ingested Auto-fetched market intel nonstop.
0 Distinct tickers Add sources to start tracking symbols
Trending sources Waiting for fresh intel
Hot tickers Surfacing from current coverage
Details Saved Published Title Source Tickers
2025-12-02 13:22 4mo ago
2025-12-02 08:10 4mo ago
Celanese Announces Cash Tender Offers for up to $1,000,000,000 Aggregate Principal Amount of 6.665% Senior Notes due 2027 and 6.850% Senior Notes due 2028 stocknewsapi
CE
DALLAS, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Celanese Corporation (NYSE: CE) (“Celanese”), a global chemical and specialty materials company, today announced that its direct wholly-owned subsidiary Celanese US Holdings LLC (the “Company”) has commenced offers to purchase for cash up to $1,000,000,000 aggregate principal amount (as such amount may be increased or decreased subject to applicable law, the “Maximum Tender Amount”) of its outstanding (i) 6.665% Senior Notes due 2027 (the “2027 Notes”) and (ii) 6.850% Senior Notes due 2028 (the “2028 Notes” and, together with the 2027 Notes, the “Notes”) as described in the table below (the “Tender Offers”). No more than $100,000,000 aggregate principal amount of the 2028 Notes will be purchased in the Tender Offer for the 2028 Notes (as may be increased by the Company, the “Series Cap”).

The Tender Offers are being made upon the terms and subject to the conditions set forth in the offer to purchase dated December 2, 2025 (the “Offer to Purchase”). Notes purchased in the Tender Offers will be retired and cancelled. Terms not defined in this announcement have the meanings given to them in the Offer to Purchase. Copies of the Offer to Purchase are available to holders through the information and tender agent, D.F. King & Co., Inc., at (212) 269-5550 (for banks and brokers) or (800) 967-4607 (all others, toll-free) in New York or by email at [email protected].

Title of
Security(a)CUSIP / ISINOutstanding Principal AmountAcceptance Priority LevelSeries Cap(c)Tender Offer Consideration (per $1,000)(d)Early Tender Payment (per $1,000)(d)Total Consideration (per $1,000)(d)6.665% Senior Notes due 2027 (the “2027 Notes”)(b)15089QAM6 / US15089QAM69$1,500,000,0001N/A$987.50$50.00$1,037.506.850% Senior Notes due 2028 (the “2028 Notes”)(b)15089QAW4 / US15089QAW42$1,000,000,0002$100,000,000$1,005.00$50.00$1,055.00 (a) The Notes are guaranteed on a senior basis by Celanese and by each of the Company’s current and future domestic subsidiaries that guarantee the Company’s obligations under its senior credit facilities. As of the next interest payment date, the interest rate payable on the 2027 Notes will be 7.165% and the interest rate payable on the 2028 Notes will be 7.350%.   (b) As of the date of the Offer to Purchase, the interest rate payable on the 2027 Notes has increased by 0.50% from the original stated coupon of 6.165%, and the interest rate payable on the 2028 Notes has increased by 0.50% from the original stated coupon of 6.350%.   (c) The Series Cap represents the maximum aggregate principal amount of 2028 Notes that will be purchased. The Company reserves the right, but is under no obligation, to increase, decrease or eliminate the Series Cap at any time, subject to applicable law.   (d) Payable in cash per each $1,000 principal amount, as applicable, of the specified series of Notes validly tendered and not validly withdrawn at or prior to the Early Tender Time (as defined below) and accepted for purchase. The Total Consideration includes the Early Tender Payment (as defined below).    The Tender Offers will expire at 5:00 p.m., New York City time, on December 31, 2025, unless extended or earlier terminated (such time and date, as the same may be extended, the “Expiration Time”). Holders must validly tender and not validly withdraw their Notes prior to 5:00 p.m., New York City time, on December 15, 2025, unless extended (such time and date, as the same may be extended, the “Early Tender Time”), to be eligible to receive the applicable Total Consideration (as defined below) which already includes an amount in cash (the “Early Tender Payment”) equal to the applicable amount set forth in the table above under the heading “Early Tender Payment”, plus accrued and unpaid interest. Holders who validly tender their Notes after the Early Tender Time but at or prior to the Expiration Time will be eligible to receive only the applicable Tender Offer Consideration (as defined below), which is an amount equal to the applicable Total Consideration minus the applicable Early Tender Payment.

Notes tendered may be withdrawn at any time prior to, but not after, 5:00 p.m., New York City time, on December 15, 2025 (such time and date, as it may be extended, the “Withdrawal Deadline”). The Tender Offers are subject to the satisfaction of certain conditions, as set forth in the Offer to Purchase; these conditions include the “Financing Condition”, by which is meant the completion of a concurrent offering by the Company of new debt securities that closes no later than the Early Settlement Date (as defined below), on terms satisfactory to the Company (in its discretion), including but not limited to the amount of net proceeds raised by such offering being sufficient to effect the repurchase of the Notes validly tendered and accepted for purchase pursuant to the Tender Offers.

The aggregate purchase price plus accrued and unpaid interest for Notes that are validly tendered and not validly withdrawn before the Early Tender Time and accepted for purchase will be paid by the Company in same day funds promptly following the Early Tender Time (the “Early Settlement Date”). The Company expects that the Early Settlement Date will be December 17, 2025, the second business day following the Early Tender Time. The aggregate purchase price plus accrued and unpaid interest for Notes that are validly tendered after the Early Tender Time and before the Expiration Time and accepted for purchase will be paid by the Company in same day funds promptly following the Expiration Time (the “Final Settlement Date”). The Company expects that the Final Settlement Date will be January 5, 2026, the second business day after the Expiration Time, assuming neither the Maximum Tender Amount nor the Series Cap is reached at the Early Tender Time. No tenders will be valid if submitted after the Expiration Date.

The Notes accepted for payment on the Early Settlement Date or the Final Settlement Date, as applicable, will be accepted in accordance with their Acceptance Priority Level set forth in the table above (with 1 being the highest Acceptance Priority Level and 2 being the lowest Acceptance Priority Level), provided that the Company will only accept for purchase Notes in an aggregate principal amount up to the Maximum Tender Amount and that Notes tendered at or prior to the Early Tender Time will be accepted for purchase with priority over Notes tendered after the Early Tender Time, but at or prior to the Expiration Time, regardless of the priority of the series of such later tendered Notes. Subject to applicable law, the Company reserves the right, but is under no obligation to, increase, decrease, or eliminate the Series Cap at any time without extending the Withdrawal Deadline or otherwise reinstating withdrawal rights of Holders. As more fully described in the Offer to Purchase, if the Series Cap is reached at or prior to the Early Tender Time, no 2028 Notes that are tendered after the Early Tender Time will be accepted for purchase, unless the Company increases the Series Cap.

The purchase of any series of Notes is not conditioned upon the purchase of any other series of Notes. Any Notes validly tendered (and not validly withdrawn) and accepted for purchase may be subject to proration as described in the Offer to Purchase. Holders of Notes that are validly tendered and not validly withdrawn at or prior to the Early Tender Time and that are accepted for purchase will receive the applicable “Total Consideration”, which already includes the Early Tender Payment for the applicable series of Notes set forth in the table above.

Holders of any Notes that are validly tendered after the Early Tender Time but at or before the Expiration Time and that are accepted for purchase will receive the applicable Total Consideration minus the Early Tender Payment (the “Tender Offer Consideration”).

Holders are advised to check with any bank, securities broker or other intermediary through which they hold their Notes as to when such intermediary needs to receive instructions from a holder in order for that holder to be able to participate in the Tender Offers before the deadlines specified herein and in the Offer to Purchase. The deadlines set by the clearing system for the submission and withdrawal of tender instructions will also be earlier than the relevant deadlines specified herein and in the Offer to Purchase.

The Company has retained BofA Securities as Lead Dealer Manager, and Citigroup, Deutsche Bank Securities and TD Securities as Co-Dealer Managers for the Tender Offers (collectively, the “Dealer Managers”). The Company has retained D.F. King as the Information and Tender Agent for the Tender Offers.

For additional information regarding terms and conditions of the Tender Offers please contact: BofA Securities at (888) 292-0070 (toll free) or (980) 388-3646 (collected). Requests for documents and questions regarding tendering of securities may be directed to D.F. King at +1 (212) 269-5550 (for banks and brokers only) or +1 (800) 967-4607 (for all others, toll-free) in New York, or by email at [email protected] or to BofA Securities at its respective telephone numbers. Copies of the Offer to Purchase and other documents relating to the Tender Offers may also be obtained at https://clients.dfkingltd.com/CE.   

This announcement is neither an offer to purchase nor a solicitation of an offer to sell the Notes. The Tender Offers are made only by the Offer to Purchase, and the information in this announcement is qualified by reference to the Offer to Purchase dated December 2, 2025. There is no separate letter of transmittal in connection with the Offer to Purchase. None of the Company, Celanese, the Celanese Board of Directors, the Dealer Managers, the Information and Tender Agent or the trustees with respect to any Notes is making any recommendation as to whether holders should tender any Notes in response to the Tender Offers, and neither the Company nor any such other person has authorized any person to make any such recommendation. Holders must make their own decision as to whether to tender any of their Notes, and, if so, the principal amount of Notes to tender.

Legal Notices

None of the Dealer Managers (nor any of their respective directors, officers, employees, agents or affiliates) has any role in relation to any part of the Tender Offers made to Holders of Notes.

This announcement is for informational purposes only and is not an offer to sell or purchase, a solicitation of an offer to purchase or a solicitation of consents with respect to any securities. There will be no sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

This announcement does not describe all the material terms of the Tender Offers and no decision should be made by any Holder on the basis of this announcement. The terms and conditions of the Tender Offers are described in the Offer to Purchase. This announcement must be read in conjunction with the Offer to Purchase. The Offer to Purchase contains important information which should be read carefully before any decision is made with respect to the Tender Offers. If any Holder is in any doubt as to the contents of this announcement, or the Offer to Purchase, or the action it should take, it is recommended that the Holder seek its own financial and legal advice, including in respect of any tax consequences, immediately from its stockbroker, bank manager, solicitor, accountant or other independent financial, tax or legal adviser. Any individual or company whose Notes are held on its behalf by a broker, dealer, bank, custodian, trust company or other nominee must contact such entity if it wishes to tender such Notes pursuant to the Tender Offers.

None of the Company, the Dealer Managers or their affiliates, their respective boards of directors, the Information and Tender Agent, the trustee with respect to the Notes or any of their respective affiliates makes any recommendation, or has expressed an opinion, as to whether or not Holders should tender their Notes, or refrain from doing so, pursuant to the Tender Offers. Each Holder should make its own decision as to whether to tender its Notes and if so, the principal amount of the Notes to tender.

The Company has not filed this announcement or the Offer to Purchase with, and they have not been reviewed by, any federal or state securities commission or regulatory authority of any country. No authority has passed upon the accuracy or adequacy of the Tender Offers, and it is unlawful and may be a criminal offense to make any representation to the contrary.

The Offer to Purchase does not constitute an offer to purchase Notes in any jurisdiction in which, or to or from any person to or from whom, it is unlawful to make such offer under applicable securities or blue sky laws. The distribution of the Offer to Purchase in certain jurisdictions is restricted by law. Persons into whose possession the Offer to Purchase comes are required by each of the Company, the Dealer Managers, the Information and Tender Agent to inform themselves about, and to observe, any such restrictions.

About Celanese

Celanese Corporation is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. Our businesses use our chemistry, technology and commercial expertise to create value for our customers, employees and shareholders. We support sustainability by responsibly managing the materials we create and growing our portfolio of sustainable products to meet customer and societal demand. We strive to make a positive impact in our communities and to foster inclusivity across our teams. Celanese Corporation is a Fortune 500 company that employs more than 11,000 employees worldwide with 2024 net sales of $10.3 billion.

Forward-Looking Statements

This announcement may contain “forward-looking statements,” which include information concerning the expected timing of the Tender Offers, our ability to complete the Tender Offers, other terms of the Tender Offers including the Financing Condition and the other conditions set forth in the Offer to Purchase, the successful completion of the concurrent notes offering, and other information that is not historical information. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that Company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the results expressed or implied by the forward-looking statements contained in this announcement. Numerous other factors, many of which are beyond Celanese’s control, could cause actual results to differ materially from those expressed as forward-looking statements. Other risk factors include those that are discussed in Celanese’s filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and neither the Company nor Celanese undertake any obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.

Celanese Contacts:

Investor Relations
Bill Cunningham
Phone: +1 302 772 5231
[email protected]

Media - U.S.
Jamaison Schuler
Phone: +1 972 443 4400
[email protected]

Media - Europe
Petra Czugler
Phone: +49 69 45009 1206
[email protected]

Source: Celanese Corporation
2025-12-02 13:22 4mo ago
2025-12-02 08:10 4mo ago
Lucid (NASDAQ: LCID) Stock Price Prediction and Forecast 2025-2030 (Dec 2025) stocknewsapi
LCID
Late last year, Lucid Group Inc. (NASDAQ: LCID) began production of its highly anticipated Gravity luxury electric SUV.
2025-12-02 13:22 4mo ago
2025-12-02 08:10 4mo ago
CleanSpark: One Of The Cheapest Miners Pivoting To AI/HPC Compute stocknewsapi
CLSK
HomeMarket OutlookCryptocurrency Tech 

SummaryI believe the core upside is CleanSpark’s potential AI/HPC second act, built on contracted power and ready sites (Sandersville, GA and Texas) that could attract hyperscaler leases before 2027.
The stock’s 50% jump last week reflects a narrative shift from pure bitcoin miner to digital infrastructure platform, even though AI compute contributes $0 revenue today.
Valuation looks cheap: ~18x next year’s earnings, about 40% below the IT sector median, and the lowest P/S among peers pivoting toward AI compute.
I remain bullish, monitoring lease agreements at Sandersville (250 MW) and Texas (285 MW), which are critical to the company's AI strategy.
Remigiusz Gora/iStock via Getty Images

I initiate coverage on CleanSpark, Inc. (CLSK) after the stock surged 50% last week on a narrative shift from just another bitcoin miner to a prospective AI/HPC digital infrastructure platform.

I am bullish on

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Quick Insights

Recommended For You
2025-12-02 13:22 4mo ago
2025-12-02 08:10 4mo ago
Steel Dynamics Secures Complete Ownership of New Process Steel stocknewsapi
STLD
Key Takeaways Steel Dynamics acquired the remaining 55% of New Process Steel to take full ownership. The move expands STLD's value-added manufacturing capabilities. New Process Steel's role as a major flat-rolled customer makes the integration synergistic.
Steel Dynamics, Inc. (STLD - Free Report) announced that it has completed the acquisition of the remaining 55% ownership interest in New Process Steel, bringing its total stake to 100%. The transaction follows the company’s earlier purchase of a 45% minority interest in 2022. The full buyout is intended to strengthen Steel Dynamics’ value-added manufacturing capabilities while deepening its long-standing commercial relationship with New Process Steel. 

Steel Dynamics highlighted New Process Steel as a highly respected metals solutions and distribution company with a strong operational footprint across the United States and Mexico. The company noted that New Process Steel has established a reputation for quality manufacturing, supply-chain reliability and long-standing customer partnerships, qualities that Steel Dynamics views as integral to its own strategic expansion into value-added steel processing. 

Steel Dynamics emphasized that acquiring full ownership will enhance its exposure to differentiated and higher-margin opportunities within the value-added manufacturing space. The transaction aligns with its broader strategy of expanding manufacturing capabilities that complement its flat-rolled steel operations. Management highlighted that New Process Steel has been one of Steel Dynamics’ largest flat-rolled customers, making the integration both commercially and operationally synergistic. 

Shares of STLD are up 17.1% over the past year compared with its industry’s rise of 17.2% 

Image Source: Zacks Investment Research

STLD Zacks Rank & Key PicksSTLD currently carries a Zacks Rank of #3 (Hold). 

Some better-ranked stocks in the Basic Materials space are Equinox Gold Corp. (EQX - Free Report) , Fortuna Mining Corp. (FSM - Free Report)  and Harmony Gold Mining Company Limited (HMY - Free Report) . EQX, FSM and HMY carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) here.

The Zacks Consensus Estimate for EQX’s current fiscal-year earnings is pegged at 52 cents per share, indicating a 160% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in two of the trailing four quarters and missed twice, with an average surprise of 87%. 

The Zacks Consensus Estimate for FSM’s current fiscal-year earnings stands at 83 cents per share, implying an 80.4% year-over-year increase. FSM’s shares have surged 118.5% in the past year. 

The Zacks Consensus Estimate for HMY’s 2026 earnings is pegged at $2.68 per share, indicating a rise of 111% from the year-ago level. HMY’s shares have gained 118.7% in the past year. 
2025-12-02 13:22 4mo ago
2025-12-02 08:10 4mo ago
Bear Of The Day: F5 (FFIV) stocknewsapi
FFIV
F5 (FFIV - Free Report) is a Zacks Rank #5 (Strong Sell) despite recently beating the Zacks Consensus Estimate. The stock has a Zacks Style Score for Value of F and a B for Growth.  This article will look at why this stock is a Zacks Rank #5 (Strong Sell) as it is the Bear of the Day.

Description                                             

F5, Inc. engages in the business of multi-cloud application services. The firm's products include F5 distributed cloud services, F5 NGINX, F5 BIG-IP, and F5 Systems. It operates through the following geographical segments: Americas, EMEA, and APAC. The company was founded on February 26, 1996 and is headquartered in Seattle, WA.

Earnings History

When I look at a stock, the first thing I do is look to see if the company is beating the number.  This tells me right away where the market’s expectations have been for the company and how management has communicated to the market.  A stock that consistently beats has management communicating expectations to Wall Street that can be achieved.  That is what you want to see.

In the case F5 (FFIV - Free Report)  I see the company has beaten the Zacks Consensus Estimate in each of the last four quarters. This alone does not make the stock a Zacks Rank #1 (Strong Buy) and it doesn’t make it a Zacks Rank #5 (Strong Sell) either.

The Zacks Rank does care about the earnings history, but it is much more heavily influenced by the movement of earnings estimates.

The most recent quarter saw the company report EPS of $4.39 when the consensus was calling for $3.96. 

Earnings Estimates

The Zacks Rank tells us which stocks are seeing earnings estimates move higher or in this case lower.  For F5 (FFIV - Free Report) I see annual estimates for next year moving lower of late.

The current fiscal year consensus number has slid from $16.00 to $14.99 over the last 90 days. 

The next fiscal year has moved from $16.94 to $16.10 over the last 90 days.

Negative movement in earnings estimates like that is why this stock is a Zacks Rank #5 (Strong Sell).

It should be noted that a lot of stocks in the Zacks universe are seeing negative earnings estimate revisions.  That means that the stocks that are seeing small but negative earnings estimate revisions are falling to a Zacks Rank #5 (Strong Sell).
2025-12-02 13:22 4mo ago
2025-12-02 08:10 4mo ago
Bull of the Day: Cirrus Logic (CRUS) stocknewsapi
CRUS
Cirrus Logic (CRUS - Free Report) is a Zacks Rank #1 (Strong Buy) that has a C for Value and a D for Growth. This company is a fabless semiconductor supplier and the chip sector remains very hot.  The Zacks Style Score for Value is only a C, but I think that grade is rather low as most of the metrics investors typically look to are very good. Let’s learn more about why this stock is the Bull of the Day.

Description                                              

Cirrus Logic, Inc. engages in the development of mixed-signal processing solutions. Its product lines include audio and High-Performance Mixed-Signal (HPMS) products. It operates through the following geographical segments: China, Hong Kong, Vietnam, South Korea, India, United States, and Rest of World. The company was founded by Suhas S. Patil and Michael L. Hackworth in 1984 and is headquartered in Austin, TX.

Earnings History                                                         

When I look at a stock, the first thing I do is look to see if the company is beating the number.  This tells me right away where the market’s expectations have been for the company and how management has communicated to the market.  A stock that consistently beats has management communicating expectations to Wall Street that can be achieved.  That is what you want to see.

Cirrus Logic (CRUS - Free Report) has topped the Zacks Consensus Estimate in each of the last four quarters. The company most recently posted EPS of $2.83 per shar when the Zacks Consensus Estimate was calling for $2.40.  That 43 cent beat translates into a 17.9% positive earnings surprise.

Over the last four quarters the average positive surprise works out to be 31%.

Earnings Estimates Revisions

Earnings estimate revisions is what the Zacks Rank is all about. 

Estimates are moving higher for Cirrus Logic (CRUS - Free Report) .

The full year 2025 has increased from $7.07 to $7.73 over the last 60 days.

2026 has increased from $7.05 to $7.32 over the same time period.

Valuation                                                                                                        

The valuation for Cirrus Logic (CRUS - Free Report) is interesting given the growth prospects. Forward earnings multiple of 15.5x is pretty low due to the fact that this fiscal year revenue is projected to contract by 1.65%.  Next fiscal year the company is expected to see revenue growth of 1.2%.  The price to book multiple comes in just a hair over 3x and that is the level that will keep value investors interested in this stock.

Operating margins have increased from 17.9% to 18.5% to 19.8% over the last three quarters.  
2025-12-02 13:22 4mo ago
2025-12-02 08:11 4mo ago
The Cheesecake Factory's Peppermint Stick Chocolate Swirl Cheesecake and Special Holiday Gift Card Offer Return stocknewsapi
CAKE
CALABASAS HILLS, Calif.--(BUSINESS WIRE)--The Cheesecake Factory® (NASDAQ: CAKE) known for its extensive menu, generous portions and legendary desserts, is bringing back its Peppermint Stick Chocolate Swirl Cheesecake for the holidays. This festive flavor features peppermint swirled with white and dark chocolate cheesecake all on a delicious mint chocolate brownie, and is now available at all The Cheesecake Factory restaurants nationwide. Additionally, The Cheesecake Factory is featuring a spec.
2025-12-02 13:22 4mo ago
2025-12-02 08:11 4mo ago
Beyond Meat stock is surging as meme mania returns: Here's the latest on the volatile start to December markets stocknewsapi
BYND
Shares in Beyond Meat (Nasdaq: BYND) are again rising in premarket trading today after the company's stock price surged a massive 36.4% yesterday.
2025-12-02 13:22 4mo ago
2025-12-02 08:13 4mo ago
Windjammer Capital Completes Sale of Paragon Energy Solutions stocknewsapi
MIR
NEWPORT BEACH, Calif. & WALTHAM, Mass.--(BUSINESS WIRE)--Windjammer Capital Investors (“Windjammer”) is pleased to announce the sale of its portfolio company Paragon Energy Solutions (“Paragon” or the “Company”) to Mirion Technologies, Inc. (NYSE: MIR, “Mirion”). Based in Fort Worth, Texas, Paragon is a leading provider of highly engineered solutions for large-scale nuclear power plants and small modular reactors (“SMRs”). The Company provides a wide range of products including electrical, sens.
2025-12-02 13:22 4mo ago
2025-12-02 07:40 4mo ago
Crypto Price Analysis 12-2: BITCOIN: BTC, ETHEREUM: ETH, SOLANA: SOL, FILECOIN: FIL, INTERNET COMPUTER: ICP cryptonews
BTC ETH FIL ICP SOL
The cryptocurrency market was mixed over the past 24 hours, with some tokens, like Bitcoin (BTC), trading in positive territory, while others, like Ethereum (ETH), were in the red. BTC fell to an intraday low of $83,909 on Monday with selling pressure persisting.
2025-12-02 13:22 4mo ago
2025-12-02 07:43 4mo ago
Eric Balchunas Pushes Back on Citi's BTC ETF Outflow Narrative cryptonews
BTC
TL;DR

Bitcoin’s price fell over 33% from its all-time high near $126,000.
Analysts debated whether massive ETF outflows were the primary cause of the drop.
Vanguard reversed its policy and will now allow trading of crypto-linked funds.

The price of Bitcoin dropped over 33% from its record peak near $126,000, erasing weeks of gains and triggering widespread liquidation across the crypto sector. As of early December, Bitcoin trades between $84,000 and $86,500, with fear indicators flashing red. Many investors secured profits while institutional selling deepened the decline.

At the same time, US spot Bitcoin ETFs recorded some of their largest redemptions to date, raising debate over their influence on price.

Analysts at Citi Bank reignited controversy by claiming that ETF outflows directly contributed to Bitcoin’s decline. Their report calculated that each $1 billion withdrawn from US spot ETFs correlates with a 3.4% price drop in Bitcoin. The conclusion portrayed ETF flows as a primary driver of downward momentum in November.

Bloomberg’s Eric Balchunas, senior ETF analyst, strongly disagreed. In a post on X, he argued that the Citi model ignored year-to-date inflows of $22.5 billion into Bitcoin ETFs.

Starting tmrw vanguard will allow ETFs and MFs tracking bitcoin and select other cryptos to begin trading on their platform. They cite how the ETfs have been tested performed as designed through multiple periods of volatility. Story via @emily_graffeo pic.twitter.com/AKhMdR7pab

— Eric Balchunas (@EricBalchunas) December 1, 2025

Using Citi’s logic, he said, Bitcoin should have gained 77% this year—an inconsistency that exposes flaws in the correlation. Balchunas stressed that ETFs account for only around 3% of total selling pressure, and blaming them oversimplifies market behavior.

According to SoSoValue, US-listed Bitcoin ETFs saw $3.79 billion in withdrawals during November, surpassing the February record of $3.56 billion. BlackRock’s iShares Bitcoin Trust (IBIT) led redemptions with $2.47 billion, followed by Fidelity’s Wise Origin Bitcoin Fund (FBTC) with $1.09 billion.

Combined, both funds represented over 90% of all redemptions, concentrating selling among large institutional vehicles. Citi strategist Alex Sonders explained that ETF creation and redemption mechanisms tie directly to Bitcoin’s spot price, as authorized participants must buy or sell Bitcoin to balance investor demand.

The selloff extended beyond ETFs
Open interest in Bitcoin derivatives dropped 35% from October peaks, according to CoinGlass. Traders who once relied on leverage liquidated positions entirely, fearing a repeat of the October 10 wipeout event. By the end of November, Bitcoin’s market structure showed clear risk aversion as margin exposure collapsed and liquidity pools thinned.

Recent ETF data pointed to a brief recovery in flows. Farside Investors reported $8.5 million in net inflows on Monday, marking the fourth consecutive day of positive movement. While IBIT logged $74 million in redemptions, FBTC attracted $67 million, and ARK Invest’s ARKB added $7.38 million, helping balance aggregate inflows. Despite the improvement, Bitcoin failed to sustain a rebound, slipping from $92,000 to $86,500 within two sessions.

Vanguard made a headline-grabbing policy reversal
The broker, with 50 million brokerage clients, now allows trading of crypto-focused ETFs and mutual funds—a sharp departure from its previous stance that labeled cryptocurrencies “too speculative.” Starting Tuesday, Vanguard clients can trade funds with exposure to Bitcoin, Ethereum, XRP, and Solana, marking a historic step toward mainstream crypto integration.

Andrew Kadjeski, head of brokerage and investments at Vanguard, stated that crypto ETFs have proven resilient, maintaining liquidity through volatile periods. He emphasized that such funds have functioned as designed, handling redemptions and new inflows even during price shocks.
2025-12-02 13:22 4mo ago
2025-12-02 07:44 4mo ago
Next 1000x Crypto to Buy After Bitcoin's November Stress Test cryptonews
BTC
What to Know:

Bitcoin’s November selloff showed that DeFi and core crypto infrastructure are tougher than they look, boosting the case for real utility 1000x plays. 
Bitcoin Hyper ($HYPER) brings SVM execution and ultra low latency smart contracts to Bitcoin, aiming for high speed wrapped $BTC DeFi on a modular Layer 2.
PEPENODE ($PEPENODE) reshapes meme coins with a mine to earn virtual node system that rewards engagement instead of blind speculation.
Cardano ($ADA) keeps building as a research driven base layer, supported by Hydra scaling and new exposure through the Brave wallet.

Bitcoin’s November crash looked painful on the charts. Prices swung double digits in days, and every social media chart wizard acted like the sky was falling.

But under the surface, something more interesting happened.

DeFi infrastructure held. Trades cleared. Liquidations worked. Yield strategies kept running. There were no chain meltdowns or domino style collapses like in previous cycles.

Source: DefiLlama
It was boring in the best possible way.

That resilience matters. It shows that capital is finally shifting to systems that actually work during volatility. Not the hype coins that vanish after one bad weekend, but the rails that keep the market running when the heat turns up. 

If you think the next 1000x crypto to buy is the project that survives these stress tests, then you’re already looking past the usual noise.

You want speed, strong security assumptions, and tech stacks that do not explode the moment gas fees spike.

Below are three new crypto projects that match that idea.

Bitcoin Hyper ($HYPER) as a bold Bitcoin Layer 2 execution engine. PEPENODE ($PEPENODE) as a mine to earn twist on memecoins. And Cardano ($ADA) as the slow and steady research chain that keeps shipping L2 capacity.

1. Bitcoin Hyper ($HYPER) – First Bitcoin L2 With SVM Execution
Bitcoin Hyper ($HYPER) calls itself the first Bitcoin Layer 2 that runs the Solana Virtual Machine.

In simple terms, it tries to bolt Solana level performance onto Bitcoin’s settlement layer. Bitcoin keeps its security. $HYPER provides the speed.

Instead of waiting for Bitcoin’s ~10 minute blocks and dealing with its limited scripting, $HYPER sends execution to a real time SVM Layer 2.

The setup is modular: Bitcoin L1 for settlement, one trusted sequencer for ordering, and an SVM execution layer that targets sub second confirmations and very low fees. It gives DeFi on Bitcoin a Solana style user experience.

Bitcoin Hyper wants wrapped $BTC to feel like a real DeFi asset. Fast payments. Tiny fees. Swaps, lending, and staking inside SVM contracts.

Even NFTs and gaming rails through Rust based SDKs. SPL compatible tokens make it easy for Solana builders to join the ecosystem.

The market seems to like the idea. The presale has already raised over $28M, and you can buy $HYPER now for just $0.013365.

Staking begins right after TGE, and presale stakers get a 7 day vesting window. It’s set up for long term participation instead of quick flips.

If you think Bitcoin’s next big move comes from fast, programmable liquidity built on Bitcoin instead of moving away from it, Bitcoin Hyper is a strong high beta bet on that future.

For more context on this project, check out Bitcoin Hyper price prediction and see what the future holds.

Join the $HYPER presale now.

2. PEPENODE ($PEPENODE) – Mine‑to‑Earn Memecoin With Node Economics
November reminded everyone that most meme coins still trade like lottery tickets taped to a roller coaster.

PEPENODE ($PEPENODE) wants to change that with a mine to earn model that rewards users for running virtual nodes and being active, not just watching charts.

The core of the system is a virtual mining setup with tiered node rewards. Engagement produces tokens and higher tier nodes lead to better performance. Users track progress through a dashboard that looks more like a simple DeFi mining UI than a standard meme page.

For a project still in presale, traction is strong. $PEPENODE has raised over $2M so far, with tokens priced at $0.0011731.

The official staking program offers 578% APY, while the node reward system works as a soft yield tool, sending new supply toward active community members instead of random speculators.

Most meme coins depend on hype loops, influencers, and luck. PEPENODE brings back a touch of early DeFi mining energy. It’s gamified, but with actual rules and transparent dashboards.

If you want meme upside without wandering around blindfolded, this one deserves a spot on your radar.

To dive deeper into the project, you can also check out PEPENODE price prediction and see how 2026 looks like for this memecoin.

Join the PEPENODE presale.

3. Cardano ($ADA) – Research‑Driven Base Layer With Hydra Scaling
Bitcoin Hyper tries to improve Bitcoin from the outside.

Cardano ($ADA) does the opposite. It builds its base layer slowly and scientifically, with formal methods and a layered design. Its Ouroboros proof of stake system aims for proof of work level security while staying energy efficient.

Cardano separates settlement and computation. This lets developers create more complex smart contracts without overloading the base chain.

Hydra adds Layer 2 scaling on top, letting apps run high throughput activity off chain and anchor back to the mainnet when needed.

The ecosystem has been expanding in the background. Brave wallet integration now gives $ADA exposure to more than 85M users.

This brings a steady flow of potential new holders and dApp users into the Cardano world. At the same time, institutions continue exploring DeFi, identity, and real world asset ideas on Cardano.

$ADA is currently trading around $0.3934, giving the network a relatively steady valuation as development keeps moving.

Source: CoinMarketCap
Cardano isn’t the loudest chain. It doesn’t shout about transactions per second every week. But its mix of formal verification, Hydra scaling, and massive user distribution makes it one of the more durable large cap platforms.

If your thesis favors slow cooking infrastructure that wins long term, ADA still belongs in the conversation.

Buy Cardano from Binance now.

Bitcoin’s November dip was more than a price correction. It was a live stress test. And the winners were the projects that kept working while everything else shook.

If Bitcoin’s future growth comes from tools that keep running during chaos, these three offer very different but very real ways to position early.

This article is for informational purposes only and doesn’t constitute financial, investment, or trading advice. Always do your own research (DYOR) before investing in crypto.

Authored by Aaron Walker, NewsBTC – https://www.newsbtc.com/news/next-1000x-crypto-to-buy-defi-recovers-after-bitcoin-crash
2025-12-02 13:22 4mo ago
2025-12-02 07:51 4mo ago
Elon Musk Issues Shock Prediction As $38.3 Trillion ‘Crisis' Primes A Bitcoin Price Boom To Rival Gold cryptonews
BTC
Elon Musk, the billionaire who controls almost $2 billion worth of bitcoin via his companies Tesla and SpaceX, has again warned the U.S. is hurtling toward a “debt crisis” that could blow up the bitcoin price.

Sign up now for CryptoCodex—A free crypto newsletter that will get you ahead of the market

The bitcoin price, which has plummeted since hitting an all-time high of $126,000 per bitcoin in early October (and may have a lot further to fall), is up almost 200% over the last two years as traders bet on the so-called debasement trade that’s also sent gold sharply higher.

Now, as traders brace for a December Federal Reserve earthquake, Musk has predicted “money disappears as a concept” in the future, with energy the only “true currency.”

Sign up now for the free CryptoCodex—A daily five-minute newsletter for traders, investors and the crypto-curious that will get you up to date and keep you ahead of the bitcoin price and crypto market swings

ForbesBitcoin Braced For A Huge December Fed Game-Changer As $6.6 Trillion Flip Predicted To Trigger Price ShockBy Billy Bambrough

Elon Musk, the Tesla, SpaceX and X chief executive, has predicted the "debt crisis" is going to change the nature of money amid a bitcoin price challenge to gold.

Getty Images

“This is why I said bitcoin is based on energy,” Musk said in an interview with Nikhil Kamath. “You can't legislate energy.”

In October, Musk posted to X that “bitcoin is based on energy: you can issue fake fiat currency, and every government in history has done so, but it is impossible to fake energy," and agreeing that the “global arms race" toward artificial intelligence is the reason why gold, silver and bitcoin have all seen their prices soar in recent years.

Bitcoin, which is secured by a network of so-called miners who use powerful computers to validate transactions in return for newly issued bitcoin, uses as much electricity each year as some small countries, with its energy demands climbing along with its price as more miners join the network.

In recent months, the “debasement trade” betting against traditional currencies like the dollar and betting on “hard” assets like gold, silver and bitcoin has taken off, with traders pushing gold, silver and the bitcoin price to record highs.

Disquiet over so-called fiat currencies has grow in the years following the huge 2008 financial crisis bailouts that directly led to the creation of bitcoin and then Covid lockdown stimulus measures that flooded the economy with trillions of freshly printed dollars.

Government stimulus and supply chain disrupting lockdowns sparked massive global inflation, which some fear has put the U.S. dollar into "death spiral" as the Federal Reserve is forced to create more dollars to pay off interest on its existing debt.

“The U.S. is increasing money supply quite substantially with deficits that are in the order of $2 trillion,” Musk told Kamath, predicting AI advances in three years will increase the output of goods and services enough to drive the economy into deflation.

“In three years or less, my guess is goods and services output will exceed the rate of inflation,” Musk said. "Maybe after those three years, you have deflation and then interest rates go to zero and then the debt is a smaller problem than it is.”

Musk, who helped Trump back into the White House with campaign rallies and warnings over the spiraling U.S. debt pile that has now passed $38 trillion, dramatically fell out with U.S. president Donald Trump after he failed to rein in government spending, while Musk’s own department of government efficiency (Doge) initiative has so far failed to make the multi-trillion dollar savings it originally promised.

Sign up now for CryptoCodex—A free crypto newsletter that will get you ahead of the market

MORE FOR YOU

ForbesIt’s ‘Finally Here’—‘Massive’ BlackRock Bitcoin ETF Update Helps Price Suddenly SoarBy Billy Bambrough

The bitcoin price has dropped sharply over the last two months, sparking fears of a bitcoin price crash even as traders and investors issue bullish bitcoin price predictions.

Forbes Digital Assets

Musk’s support for bitcoin and crypto has waned from its Covid-era peak, though Musk has continued to give backing to bitcoin, as well as his "favorite" cryptocurrency dogecoin.

Following his White House exit, Musk said his America Party would favor bitcoin over the U.S. dollar, with Musk branding the dollar and other non-asset backed currencies as “hopeless.”

This week, the bitcoin price has fallen sharply even as gold and silver have climbed, though analysts are divided over whether bitcoin will catch up.

“Quite why silver and gold are surging when bitcoin is struggling is another matter," AJ Bell investment director Russ Mould said in emailed comments.

“Adherents of cryptocurrencies argue they are every bit as much a haven asset as precious metals, and thus an equally effective source of protection against debt accumulation and currency debasement, thanks to how their supply is finite, at least when it comes to bitcoin. But crypto’s performance as an asset class generally seems to be more ‘risk on’ than ‘risk off’ and bitcoin’s latest bout of marked weakness is coinciding with a pause in U.S. equities’ relentless march higher and the first signs of some doubts over AI stocks and whether their valuations and spending plans can be truly justified.”
2025-12-02 13:22 4mo ago
2025-12-02 07:55 4mo ago
Funds routed through Tornado Cash as Goldfinch Finance user deltatiger.eth loses $330K cryptonews
ETH TORN
An identified user of the Ethereum-based DeFi platform Goldfinch Finance has suffered an exploit leading to losses of approximately $330,000, according to blockchain security platform PeckShield. PeckShieldAlert reported on X Tuesday that Goldfinch user deltatiger.eth's attacker had sent about 118 ETH to Tornado Cash after hacking an older smart contract on Ethereum.
2025-12-02 13:22 4mo ago
2025-12-02 07:55 4mo ago
LINK Price Prediction December 2025: Is a $60M LINK Short Squeeze Possible? cryptonews
LINK
The LINK price prediction December 2025 is the main topic this week with December just starting, but the attention is huge as Chainlink enters one of its most eventful weeks of the year. With exchange supplies hitting 2020 lows, whale accumulation intensifying, and the first-ever LINK ETF going live, market sentiment is shifting rapidly. As a result, many are closely tracking short-term resistances that could trigger a significant move.

LINK ETF Launch Drives Institutional AttentionIn a recent breaking news, the Grayscale announcement is the trigger for this excitement. As they confirmed that its Grayscale Chainlink Trust ETF (Ticker: GLNK) will begin trading on NYSE Arca, marking the first spot Chainlink ETF available to investors. 

This development is viewed as remarkably promising right now, as the LINK ecosystem is currently regarded as the top blue-chip crypto project, which is key for consistent future growth in blockchain technology. This places LINK crypto into a broader institutional spotlight while offering traditional market participants direct exposure to LINK price USD movements.

Moreover, Eric Balchunas confirmed this news, reinforcing expectations that the product’s launch could influence demand during December. As LINK price today hovers near key liquidity levels, traders view the ETF debut as a potential catalyst for renewed volatility.

Exchange Supply Plunges to 2020 LevelsIn parallel, on-chain data indicate that LINK supply on exchanges has decreased to levels last observed in 2020. which clearly highlights the accumulation going on alongside the panic selling.

That means once the noise settles, strong fundamental projects are going to roar massively on charts. Historically, it’s evident such declines have, for the most part, been preceded by strong upside swings. 

Meanwhile, this exchange activity gained credibility when it was noticed that a prominent whale has accumulated 2.33 million LINK worth $38.86 million over the past six months from OKX and Binance. Despite holding an unrealized loss of more than $10.5 million, the wallet continues to add to its position, reinforcing strong conviction in the long-term LINK price forecast. 

At the same time, derivatives data shows that the liquidation clusters show the strongest short interest near $13.94, forming a magnetic level for price action. If LINK reclaims this zone, the next objective sits at $14.87. Breaking both thresholds could trigger a “massive short squeeze,” potentially clearing more than $60 million in short positions accumulated over 30 days.

Adoption Metrics Hit All-Time Highs Ahead of DecemberChainlink’s ecosystem fundamentals continue to expand with notable acceleration. The Chainlink Reserve, funded through on-chain and off-chain revenue, has amazingly climbed to 973,753 LINK, showing ongoing growth and now only 27K more LINK tokens to hit 1 Million LINK tokens strategic reserve.

Furthermore, Chainlink’s adoption metrics reached all-time highs as of November 2025. Transaction Value Enabled (TVE) has hit $27.09 trillion, its not any ordinary number it means this is the cumulative amount of transactions facilitated by Chainlink oracles.

Additionally, Total Verified Messages (TVM) hit ATH too and reached 18.87 billion.

These figures underscore the network’s expanding role across smart contract operations, strengthening the argument for sustained upward pressure in the LINK price prediction December 2025.

Technical Outlook for December: Key Levels to WatchThe December outlook remains tied to short-term resistance structures. The LINK/USD $13.94 level remains the primary liquidity cluster, where heavy short leverage is concentrated. Clearing this point would set the stage for a move toward $14.87.

If the market absorbs both resistance zones, the conditions for a significant short squeeze emerge, which aligns with broader ETF-driven sentiment and on-chain metrics heading into the month. The December trajectory as highlighted in the LINK price prediction December 2025 narrative will depend entirely on how price reacts to these critical liquidity pockets.

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.
2025-12-02 13:22 4mo ago
2025-12-02 07:58 4mo ago
Bitcoin Faces Potential Support Challenges Amid Shifts in Global Liquidity cryptonews
BTC
As of December 2025, Bitcoin's price has encountered significant pressure, hovering around the $88,000 mark while facing the ramifications of global liquidity changes largely driven by Japan's monetary policies. This shift is rooted in Japan's decision to adjust its interest rates, which has had a cascading effect on various financial markets, including cryptocurrencies.
2025-12-02 13:22 4mo ago
2025-12-02 07:59 4mo ago
11 Trillion Asset Management Giant Vanguard To Allow Bitcoin, Ether, And XRP ETF Trading In Stunning About-Turn cryptonews
BTC ETH XRP
Vanguard, the world’s second-largest asset manager, is set to allow its clients to start trading crypto-focused exchange-traded funds (ETFs) and mutual funds on its platform, abandoning its previous anti-crypto stance that had kept digital-asset offerings off its shelves for years.

Starting Tuesday, Vanguard will allow trading in funds that hold cryptocurrencies like Bitcoin (BTC), Ethereum (ETH), Ripple’s XRP, and Solana (SOL), similar to how the firm treats gold, according to a Monday report from Bloomberg.

“Cryptocurrency ETFs and mutual funds have been tested through periods of market volatility, performing as designed while maintaining liquidity,” Andrew Kadjeski, Vanguard’s head of brokerage and investments, told Bloomberg. “The administrative processes to service these types of funds have matured; and investor preferences continue to evolve.”

Notably, funds linked to memecoins or those not supported by the U.S. Securities and Exchange Commission (SEC) will remain barred. Moreover, Vanguard has no immediate plans to create its own crypto products.

The pivot provides more than 50 million Vanguard brokerage customers with access to regulated crypto funds, including those from rival asset manager BlackRock.

Advertisement
 

Nearly a dozen spot Bitcoin ETFs that launched early last year attracted impressive inflows, pushing their combined assets to nearly $120 billion, while ETH products grew to around $20 billion, per SoSoValue data.

Still, Vanguard astutely indicated that it would steer clear of such crypto-related investment products, citing volatility and the speculative nature of assets. As recently as August 2024, iShares veteran and current CEO Salim Ramji had ruled out any plans to offer crypto ETFs.

According to Bloomberg, the Wall Street behemoth’s decision to embrace crypto assets is a response to strong demand from retail and institutional clients despite a sharp market pullback.

Major Policy Shift To Open Crypto Floodgates
Some crypto commentators believe Vanguard’s change of heart could lead to a deluge of crypto ETF customers and act as a catalyst for crypto prices. Vanguard is second only to BlackRock as an asset manager, with roughly $11 trillion in global assets under management.

Crypto strategist Nilesh Rohilla noted on X that he would be shocked if the BTC price doesn’t “jump 5% in this news in the next 24 hrs.”

Vivek Sen, the founder of Bitcoin public relations company Bitgrow Lab, also forecasted that there are “trillions incoming.” 

Meanwhile, X user BankXRP observed: “This is another massive signal that traditional finance is fully stepping into digital assets. The wall of money is lining up.”
2025-12-02 13:22 4mo ago
2025-12-02 07:59 4mo ago
Toncoin Climbs to $1.50 as Cocoon Debut Sparks Surge in Trading Volume cryptonews
TON
Cocoon lets GPU owners rent out computing power for AI tasks and receive TON tokens as compensation, with Telegram as the first user. Dec 2, 2025, 12:59 p.m.

TON rose 0.77% in 24 hours to $1.5029 as trading activity intensified following the introduction of Cocoon, a decentralized AI compute platform built on The Open Network.

Volume spiked to 2.95 million, marking a 37% increase over the weekly average, according to CoinDesk Research's technical analysis data model.

STORY CONTINUES BELOW

The price action comes as Cocoon starts processing live user requests. The platform enables GPU owners to rent out computing power for AI inference tasks and receive TON tokens as compensation.

Telegram, which has deep ties to the TON ecosystem, is serving as the first user of Cocoon’s AI infrastructure.

While TON’s gains trail broader crypto benchmarks, underperforming the CoinDesk 20 (CD20) index, which rose by 1.47% in the period, the surge in volume suggests large market particpants may be building positions.

Despite dips to a session low of $1.4501, the token showed strength through the period, closing well above its open of $1.4914 and holding onto the key support level around $1.45.

The price remained confined within a narrow range, suggesting a consolidation phase. Still, the elevated volume and ecosystem developments point to growing interest in TON’s role as infrastructure for decentralized AI.

Support is also seen around $1.44, with resistance near $1.51. A sustained move above that level could set up a test of $1.53 in the near term.

Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy.

More For You

Protocol Research: GoPlus Security

Nov 14, 2025

What to know:

As of October 2025, GoPlus has generated $4.7M in total revenue across its product lines. The GoPlus App is the primary revenue driver, contributing $2.5M (approx. 53%), followed by the SafeToken Protocol at $1.7M.GoPlus Intelligence's Token Security API averaged 717 million monthly calls year-to-date in 2025 , with a peak of nearly 1 billion calls in February 2025. Total blockchain-level requests, including transaction simulations, averaged an additional 350 million per month.Since its January 2025 launch , the $GPS token has registered over $5B in total spot volume and $10B in derivatives volume in 2025. Monthly spot volume peaked in March 2025 at over $1.1B , while derivatives volume peaked the same month at over $4B.View Full Report

More For You

APT Rises 2.3%, Outperforms Wider Crypto Market

54 minutes ago

The gains were accompanied by a surge in trading volume signaling potential institutional positioning.

What to know:

APT advanced 2.4% to $1.90.Trading volume jumped 40% above the 30-day average.Read full story
2025-12-02 13:22 4mo ago
2025-12-02 07:59 4mo ago
Bitcoin miners face worst profitability crunch on record, analyst says cryptonews
BTC
While BTC has rebounded above $87,000 after a harsh selloff, analysts say liquidity has returned without momentum.
2025-12-02 13:22 4mo ago
2025-12-02 08:00 4mo ago
ZCash drops 53% in two weeks – Is this the end of an explosive cycle? cryptonews
ZEC
Journalist

Posted: December 2, 2025

ZCash has been an extreme outlier in price performance among the relatively large-cap assets in the crypto market. Its run began in September, as the privacy narrative gathered steam. The rally intensified in October.

Measured from September’s low at $38.69 to the November high of $750, the rally was a whopping 1,838.5%. This was an 18-fold return in under 10 weeks.

The peak in the first week of November, combined with the market-wide sentiment slump and Bitcoin’s [BTC] loss of the $100k level, might have ended Zcash’s [ZEC] bull run.

From a technical perspective, it can be argued that this was only a retracement phase.

An AMBCrypto report from November stressed the importance of profit-taking at the 100% Fibonacci extension level. Those levels were plotted based on the previous cycle’s swing points.

A 53% price drop in the past fortnight vindicated the earlier predictions. What can come next?

Long-term structure vs. short-term bearishness

Source: ZEC/USDT on TradingView

The 1-day timeframe saw an internal shift towards bearishness.

The higher low at $470 was breached nearly ten days ago. The recent downturn below the swing low at $424 highlighted the onset of the retracement phase. It also warned of a potential downtrend.

However, the Fibonacci retracement levels of the current run supported the idea that the rally was not over. The 78.6% retracement level has not been breached yet.

Source: ZEC/USDT on TradingView

The hourly chart did not show potential for a sizeable bounce. Here, too, the structure was bearish. The $400-$420 region had an imbalance and can act as a supply zone.

ZCash: Piecing together the technicals
In both the timeframes, the MFI showed bears were in control. Momentum and capital flow were in favor of the sellers. The daily chart showed the MFI shift to bearishness in recent days, with a drop below 20.

The hourly chart showed that ZCash was highly likely to experience more losses soon.

The OBV was not in a sizeable slump on the daily chart, but it was sliding lower on the hourly timeframe. This supported the retracement phase argument.

Key support and resistance levels
The $400-$420 was a strong short-term resistance. The $315-$321 support is being defended, but is likely to be lost soon. A daily session close below $315 would be a signal to sell.

A slide to the next Fibonacci retracement support at $197 can be expected.

Final Thoughts

Traders can maintain a long-term bullish outlook, based on the Fibonacci retracement levels and the importance of the $200 level.
Investors must be careful holding on to ZEC at a time when Bitcoin seems to be transitioning to a bear market.

Disclaimer: The information presented does not constitute financial, investment, trading, or other types of advice and is solely the writer’s opinion

Akashnath S is a Senior Journalist and Technical Analysis expert at AMBCrypto. He specializes in dissecting price action, identifying key market trends through advanced chart patterns, and forecasting both short-term and long-term asset trajectories.
His distinct analytical method is grounded in his academic training as a Chemical Engineer. This background provides him with a systematic, process-oriented approach to market data, enabling him to analyze the complex dynamics of financial markets with precision and objectivity.
Having actively covered the cryptocurrency space since the landmark 2017 market cycle, Akashnath possesses years of experience navigating both bull and bear markets. This seasoned perspective is critical to his insightful reporting on market volatility and evolution.
As an active market participant, Akashnath enhances his analysis with crucial, hands-on experience. This practical application of his technical skills ensures his insights are not merely theoretical, but are also relevant and actionable for an audience looking to understand and navigate trading opportunities. He is dedicated to educating readers on the nuances of technical analysis, empowering them with the knowledge to make more informed financial decisions.
2025-12-02 13:22 4mo ago
2025-12-02 08:00 4mo ago
Brace For Impact: XRP Price Has Formed A Bullish Cross On Its Weekly Stochastic RSI cryptonews
XRP
XRP price has formed a bullish cross on its weekly Stochastic RSI, creating a bullish sign for the cryptocurrency at a time when its price has been struggling to break away from the $2 region. The cryptocurrency has spent the past several days moving into a downturn, and buyers will now be looking to defend $2.

Even though momentum has been limited, new inflows from recently launched XRP ETFs have kept sentiment from turning full-on bearish. 

XRP Stochastic RSI Undergoes Bullish Weekly Cross
According to crypto analyst ChartNerd, XRP has just printed a bullish cross on its weekly Stochastic RSI while still sitting deep in oversold territory. The chart he shared highlights how the blue %K line has curved upward and crossed above the orange %D line at one of the lowest points of the cycle. 

With this move, the indicator has now repeated a structure that previously marked major turning points during XRP’s past market swings. Oversold weekly conditions paired with a confirmed cross are useful in predicting the early stages of trend reversals, especially when they occur after extended downside momentum. 

ChartNerd pointed out that this same configuration appeared twice recently, first in 2024 and again in 2025, and both instances produced powerful rallies. The 2024 cross preceded a surge of more than 600%, at which point the XRP price went from trading around $0.5 to trading above $3. 

Source: Chart from ChartNerd on X
The mid-2025 cross delivered a smaller yet still significant 130% run, at which point the XRP price went from hovering around $2.1 to breaking new all-time highs above $3.6 in July. 

As shown in the chart below, these earlier crosses are marked at similar low points, forming a repeating rhythm of sharp recoveries whenever the weekly Stochastic RSI resets and turns up. The current setup is in the same zone, and this opens up speculation that XRP’s price action may be forming the base of its next major upward leg.

Is Another Major XRP Pump Approaching?
Although past performance does not dictate what happens next, the indicator’s consistency on the weekly timeframe is difficult to ignore. XRP’s price is again positioned inside a compressed region just as it was before its previous large rallies. This time, the price zone to take note of is around $2.

If buyers regain strength and the wider crypto market conditions improve, most notably Bitcoin climbing back above $100,000, then the probability of a stronger XRP reaction increases. The only thing going well right now for XRP is the inflows into US-based Spot XRP ETFs, with $89.65 million worth of new institutional funds coming in on December 1.

A rally similar to the 130% rebound seen during the previous cycle would lift XRP from $2 to about $4.60. A repeat of the much larger 600% surge would place the token above $14. This creates a potential range between $4.60 and $14 if the pattern repeats itself.

XRP trading at $2.0 on the 1D chart | Source: XRPUSDT on Tradingview.com
Featured image from Freepik, chart from Tradingview.com
2025-12-02 13:22 4mo ago
2025-12-02 08:00 4mo ago
BitMine Snaps Up $70 Million In Ether In Another Surprise Mega Buy cryptonews
ETH
Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure

According to on-chain tracking, BitMine added 23,773 Ether over three days as the market softened. The buying included 7,080 ETH for close to $20 million on Monday and 16,693 ETH for roughly $50 million on Saturday. Based on reports, those two transactions together pushed the firm’s recent outlay to nearly $70 million.

BitMine Steps Up Accumulation
The purchases follow a larger wave of buying from last week, when Bitwise moved 96,800 ETH for roughly $273 million. Reports have disclosed that BitMine now holds about 3.7 million Ether at an average cost of $3,008 per coin.

That puts the treasury in the red at current prices, but management appears focused on long-term targets: the firm says it is about 60% of the way toward a plan to control 5% of Ether’s supply.

The scale of that aim is unusual. Few corporate treasuries aim for a single-asset share that large. Market watchers see the moves as a clear bet that Ether will be worth substantially more over time, even if the present valuation shows paper losses. The strategy is heavy accumulation during weakness, not trading around price swings.

It seems that Tom Lee(@fundstrat)’s #Bitmine just bought another 7,080 $ETH($19.8M) 2 hours ago.https://t.co/yZbTCFm9GT pic.twitter.com/JHb3WYDa0a

— Lookonchain (@lookonchain) December 2, 2025

Tom Lee’s Targets Shift Again
Meanwhile, Tom Lee, who chairs BitMine, has stepped back from earlier, bolder forecasts for Bitcoin. He previously expected Bitcoin to reach $250,000 by the end of 2025. In recent public comments he first softened that call and then said on CNBC that Bitcoin could reach a new all-time high by the end of January. Lee tied that outcome to a recovery in equities, which he said he expects.

Source: Grayscale
Grayscale Research Counterpoints Cycle Fears
Grayscale Research released analysis pushing back against the idea that Bitcoin must follow the usual four-year halving cycle. The firm suggested BTC could make new highs in 2026 and urged investors to view large pullbacks as part of normal market swings.

Pricing data shows Bitcoin fell about 30% from its October peak through most of November, hitting roughly $84,000 briefly before edging back to about $86,909 as of early Tuesday, according to price feeds.

ETHUSD trading at $2.78 on the 24-hour chart: TradingView
Why These Moves Matter Now
Large, coordinated buying by treasury firms can shift market psychology. When groups with deep pockets step in, some traders see it as a sign of conviction. At the same time, these entities can take months or years to reach break-even if prices stay below their average purchase levels. That dynamic makes markets more sensitive to both supply concentration and the pace of future buying.

BitMine’s on-chain activity will likely draw more attention if additional large transfers appear. Shifts in the firm’s average cost per ETH may also become a talking point, along with any new remarks from Tom Lee about his updated timeline. Analysts are already examining whether Grayscale’s stance on the halving cycle gains support from other major market participants.

Featured image from BIS Safety Software, chart from TradingView

Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.
2025-12-02 13:22 4mo ago
2025-12-02 08:01 4mo ago
Bitcoin's monthly MACD turns bearish as macro pressure mounts cryptonews
BTC
Bitcoin’s monthly MACD turns bearish as BOJ tightening risks, strong dollar and ETF outflows hit liquidity, triggering liquidations and raising odds of a deeper crypto downturn.

Summary

Bitcoin’s monthly MACD histogram printed a fresh negative bar, repeating patterns that previously preceded extended market downturns since 2012.​
A macro shock from rising Japanese yields, strong dollar and higher funding costs triggered a thin‑liquidity sell-off and heavy leveraged liquidations.​
Ethereum shows a death cross and weakening structure, reinforcing the case for broader crypto weakness if Bitcoin loses its key trendline supports.

Bitcoin’s monthly Moving Average Convergence Divergence (MACD) indicator has turned bearish, marking a technical shift that has historically preceded extended downturns in the cryptocurrency market, according to technical analysis data.

The monthly MACD for Bitcoin (BTC) has remained bearish since 2022. In November, the MACD histogram printed its first negative red bar, and the cryptocurrency declined significantly that month, according to market data. Previous instances of similar monthly momentum shifts in prior cycles were followed by extended downturns and sharp declines from earlier peaks.

Leveraged traders experienced heavy liquidations in the past day, and data showed substantial liquidity positioned above current prices, according to trading platform reports. Market analysts have stated that a potential short squeeze could be significant as bearish positioning reaches extreme levels.

Bitcoin downtrend could coincide with spike in Japanese bond yields
The decline coincided with a spike in Japanese bond yields, increasing the likelihood of tighter Bank of Japan monetary policy. Rising funding costs have forced a global repricing of risk assets, with high-volatility assets such as Bitcoin responding to the shift. The sell-off occurred during a thinly traded overnight period, when order books were thin and market makers operated at reduced volume.

With exchange-traded fund flows absent during the overnight session, a macro trigger pushed the market through several support levels, triggering exchange-wide stop-loss orders and forced liquidations of leveraged positions, according to market observers. Futures on precious metals rose as the cryptocurrency fell, with safe-haven assets receiving inflows as carry-trade pressures intensified.

The monthly bearish MACD crossover has occurred during major market cycles since 2012, with extended troughs following similar signals, according to historical data. The indicator measures momentum shifts between short- and long-term price averages, with a negative reading indicating a potential reversal from bullish to bearish trend.

Current macroeconomic conditions include fiscal pressure in Japan, sustained strength in the U.S. dollar, elevated Treasury yields, and recent outflows from spot Bitcoin ETFs, factors that analysts say increase the risk of further volatility.

From a technical perspective, the first support level sits near the trendline defined by higher lows established over the past year, according to technical analysts. A break below that trendline would expose prior lows dating back to last spring and earlier price peaks.

Ethereum (ETH) has also shown weakening technical indicators, with a death cross pattern in place as its shorter moving average fell below the longer-term moving average. The combination of Bitcoin’s MACD signal and Ethereum’s technical weakness points to broader weakness across cryptocurrency markets, according to market analysts.
2025-12-02 13:22 4mo ago
2025-12-02 08:03 4mo ago
Ethereum Coil Tightens: Break to $4.5K or $7.6K Incoming? cryptonews
ETH
Ethereum trades near $2,864 as bullish wedge and inverse H&S patterns form. Analysts eye key breakout levels at $4,500 and $7,600.
2025-12-02 13:22 4mo ago
2025-12-02 08:03 4mo ago
Bitcoin's ‘more reliable' RSI variant hits bear market bottom zone at $87K cryptonews
BTC
18 minutes ago

Bitcoin velocity RSI produced a rare bear market bottom signal as BTC price losses sparked a return to extreme "oversold" conditions.

Bitcoin (BTC) is printing a key bear market bottom signal at $87,000 as analysis says that BTC price history may repeat.

Key points:

Bitcoin’s velocity RSI metric returns to levels seen only around bear market bottoms.

BTC price action could thus be performing a “major cyclical reset,” says analysis.

The crypto long/short ratio breaks a lifetime habit as Bitcoin tumbles.

Velocity RSI sees BTC price bottom in progressIn an X post on Tuesday, analyst On-Chain Mind flagged rare single-digit readings on Bitcoin’s velocity relative strength index (RSI) indicator.

Bitcoin bear market comparisons have come thick and fast in recent weeks, but now, a leading BTC price indicator demands a market bottom.

Velocity RSI, which takes into account recent price momentum changes, has now dived below 10/100 to hit some of its most “oversold” levels ever.

“The Velocity RSI on the 3-day chart has just hit its lowest reading since the bottoms of the last 3 bear markets,” On-Chain Mind said.

An accompanying chart showed similar chart setups at the end of Bitcoin’s 2018 bear market, as well as midway through 2022, around six months before the most recent true bear market found its long-term floor.

“It’s one of the more reliable, widely tracked momentum exhaustion indicators, and it’s now flashing a level we only see at major cyclical resets,” On-Chain Mind added.

“An interesting technical signal worth paying attention to.” BTC/USD three-day chart with Velocity RSI data. Source: On-Chain Mind/XBitcoin long/short ratio enters unknown territoryDepending on the perspective, current BTC price behavior stands out from past bearish phases.

Not all classic price metrics have reacted the same to the latest events, and these now include Bitcoin’s long/short ratio.

Joao Wedson, founder and CEO of crypto analytics platform Alphractal, noticed an unusual phenomenon playing out this week. 

“Over the years, we’ve identified several strong Alpha signals in the crypto market. One of the most reliable has always been this: when Bitcoin’s Long/Short Ratio rises above the average of major altcoins, it historically points to a price bottom forming. But this time something different happened,” he told X followers.

“For the first time ever, BTC kept this ratio at extremely elevated levels for an unusually long period — and yet we saw false bottom signals throughout November, while the price continued to drop.” Crypto long/short ratio data. Source: Joao Wedson/XWedson explained that the implications of this could hurt bulls. Traders being overly eager to long BTC while attempting to catch a falling knife may incentivize large-volume players to liquidate them by driving the price down further.

This article does not contain investment advice or recommendations. Every investment and trading move involves risk, and readers should conduct their own research when making a decision.
2025-12-02 13:22 4mo ago
2025-12-02 08:04 4mo ago
Grayscale Predicts Bitcoin Will Break Historical Four-Year Cycle Pattern cryptonews
BTC
Bitcoin's famous 4-year cycle may be ending, says Grayscale. Analysts cite institutional buyers, Fed policy shifts, and strong fundamentals as reasons BTC could reach new peaks in 2026.

Newton Gitonga2 min read

2 December 2025, 01:04 PM

Grayscale Research released a report on Monday challenging the widely accepted four-year cycle theory for Bitcoin. The firm argues that prices will continue to reach new peaks in 2025, rather than following the traditional pattern of dramatic crashes after each halving event.

The cryptocurrency has experienced significant turbulence since early October. Bitcoin declined 32% from its peak through late November. Monday saw prices dip to $84,000 before recovering to $86,909 by early Tuesday morning.

Latest pullback consistent with historical average. Source: Grayscale Research

The research firm acknowledged that long-term holders typically achieve profits. However, these investors must endure substantial price corrections during bull markets. Drawdowns exceeding 25% occur regularly and do not necessarily indicate the start of extended downturns.

Institutional Investment Reshapes Market DynamicsSeveral factors distinguish the current market cycle from previous patterns. The explosive price surges that typically precede major reversals have not materialized this time. Market participation has shifted dramatically toward institutional investors.

Exchange-traded products and digital asset treasuries now attract significant capital flows. This contrasts sharply with earlier cycles, which were dominated by retail traders on conventional exchanges. The change in investor composition may alter traditional price behavior patterns.

Macroeconomic conditions appear favorable for continued growth. Interest rate reductions could provide additional support. Bipartisan momentum behind cryptocurrency legislation in the United States adds another positive element to the outlook.

Market Strategists See Strong December Performance AheadTom Lee of Fundstrat Capital forecasts robust market performance through the end of the year. The research chief projects the S&P 500 could reach 7,300, representing a potential 10% increase from current levels.

Lee highlighted a crucial development affecting market liquidity. The Federal Reserve concluded its quantitative tightening program, a policy that has reduced the central bank's balance sheet since April 2022. Historical precedent suggests significant upside potential following similar shifts.

The strategist referenced September 2019 as a comparable scenario. Markets surged over 17% within three weeks after quantitative tightening ended during that period. Current conditions mirror several aspects of that environment.

November's volatility created what Lee describes as a healthy position reset. Many fund managers capitulated during the turbulence, potentially setting up favorable conditions for a rally.

Bitcoin and Ethereum have underperformed expectations in recent weeks. Prices took substantial hits in mid-October and faced additional pressure subsequently. Lee maintains that neither cryptocurrency has reached its final peak level for this cycle.

Non-Bitcoin currency assets outperformed in November. Source: Grayscale Research

ENRICH your inbox with our best storiesDon’t miss out and join our newsletter to get the latest,
well-curated news from the crypto world!

Newton Gitonga

Newton Gitonga covers cryptocurrencies, blockchain, and digital finance. He specializes in breaking down complex trends with clear, data-driven reporting. His work focuses on market analysis, technical insights, and the evolving role of altcoins in shaping global markets.

Read more about

Bitcoin
2025-12-02 13:22 4mo ago
2025-12-02 08:05 4mo ago
Yearn Finance starts asset recovery after $9 million exploit on November 30 cryptonews
YFI
Yearn Finance has started the recovery process for funds that were stolen when a $9 million exploit hit its yETH stableswap pool on November 30. The DeFi protocol announced it successfully clawed back $2.39 million worth of assets, which are to be returned to affected depositors.
2025-12-02 13:22 4mo ago
2025-12-02 08:06 4mo ago
CZ-owned Trust Wallet debuts prediction markets starting with Myriad cryptonews
XMY
Trust Wallet, the self-custodial crypto wallet owned by Binance co-founder Changpeng “CZ” Zhao, is the latest wallet to tap into prediction markets.

Trust Wallet has launched Predictions, a new wallet-native section allowing users to trade and earn on real-world events with full self-custody, the company announced Tuesday.

“Eligible users can view events, take positions on outcomes such as yes or no and track how each event develops over time, all within their existing Trust Wallet,” Trust Wallet said.

From Tuesday, Trust Wallet’s Predictions will aggregate markets from multiple platforms, enabling users to trade predictions on a wide range of topics, including crypto, politics, sports, entertainment and global events.

Kalshi and Polymarket are coming to Trust WalletTrust Wallet’s foray into prediction markets begins with an integration of the Web3 prediction market protocol Myriad and is set to expand to major platforms like Kalshi and Polymarket soon.

“Predictions is live today in Trust Wallet powered by Myriad,” Trust Wallet CEO Eowyn Chen told Cointelegraph, adding that Kalshi and Polymarket are expected to join in the coming weeks.

Weekly trading volumes on prediction markets. Source: DuneLaunched in March, Myriad is a new entrant in the prediction market space, reaching $100 million in cumulative trading volume by late November.

By comparison, data compiled by Dunedata on Dune Analytics shows that major prediction markets such as Kalshi, Opinion and Polymarket each handle about $1 billion in daily trading volume.

Uniting trading in a single interfaceTrust Wallet’s move into prediction markets came weeks after it launched tokenized stocks in collaboration with Ondo Finance in September, reflecting a trend for uniting different trading tools within one platform.

In October, major crypto wallet MetaMask announced a partnership with Polymarket, aiming to enable users to trade predictions directly from the wallet.

“People shouldn’t need five apps to express what they think will happen next,” Trust Wallet CEO Chen said, highlighting the company’s vision to unlock safe and simple access to emerging markets.

“Wallets are becoming the home for all kinds of trading — not just tokens, but also information, opinions, and expectations,” Chen noted, adding:

“Users shouldn’t need five apps to express a market opinion. It should happen in the same place they already hold and trade.”The CEO mentioned that trading restrictions, such as geofencing, are strictly enforced per prediction platform.

Magazine: Animoca’s bet on altcoin upside, analyst eyes $100K Bitcoin: Hodler’s Digest, Nov. 23 – 29
2025-12-02 13:22 4mo ago
2025-12-02 08:10 4mo ago
If You're Expecting A Bitcoin Bear Market In 2026, You Have It Wrong, Grayscale Says cryptonews
BTC
Grayscale has shot down Bitcoin (CRYPTO: BTC) price crash predictions, predicting that the next major leg could take prices beyond prior records.

Grayscale Says Current Drawdown Matches Bull-Market NormsIn its November market commentary published on Monday, Grayscale said Bitcoin's 32% drop from its October peak fits the pattern of typical bull-market pullbacks. 

It noted that Bitcoin has posted declines of 10% or more about 50 times since 2010, making sharp drawdowns a recurring feature of its cycle.

The firm's latest report said investors often underestimate how common such moves are, even during strong cycles.

The research team said it does not expect Bitcoin to enter a prolonged 2-3-year drawdown similar to past "cyclical" declines. 

Instead, the firm highlighted that the current market structure differs from prior cycles due to the influence of exchange-traded products and corporate digital asset treasuries. 

Grayscale said this shift reduces the relevance of the traditional four-year price rhythm tied to Bitcoin's supply halving.

The firm also pointed to the absence of a parabolic rally in the latest cycle — a pattern that previously preceded multi-year crashes. 

It said this moderation, combined with evolving market participation, supports a more constructive outlook for 2025 and 2026.

Hedging Activity And On-Chain Signals Indicate Bottoming EffortGrayscale noted that Bitcoin put-option skew remains elevated across three and six-month tenors, signaling active downside hedging. 

The firm said such positioning has historically appeared near market lows. 

It also highlighted that major digital asset treasuries are trading at discounts to their net asset values, which may reflect reduced speculative exposure.

However, the short-term picture is still mixed. 

Futures open interest has declined, and exchange-traded product flows were negative for most of November. 

On-chain data showed another spike in Coin Days Destroyed, indicating movement of older Bitcoin that may have belonged to longtime holders.

Grayscale said a clearer bottom requires improvement in flows, stabilization in open interest, and a slowdown in "OG" selling.

Privacy Assets Outperform As Market RotatesPrivacy-focused cryptocurrencies outperformed the broader market in November, with Zcash (CRYPTO: ZEC), Monero (CRYPTO: XMR), and Decred (CRYPTO: DCR) posting double-digit gains.

The rally reflected increased developer activity around privacy tools being built within the Ethereum ecosystem.

Grayscale said privacy is emerging as a defining theme for the next stage of digital asset utility, citing new frameworks and Layer-2 developments.

The firm said XRP (CRYPTO: XRP) and Dogecoin (CRYPTO: DOGE) exchange-traded products began trading under new SEC listing standards. 

It said the change expands institutional access to large-cap tokens and broadens the eligible universe for regulated products.

Macro Setup May Support Crypto Into 2026The report said the broader backdrop remains favorable, with investors watching the Federal Reserve's Dec. 10 meeting for a possible rate cut. 

Lower real interest rates typically weigh on the U.S. Dollar and support alternative assets including Bitcoin.

Grayscale also cited ongoing bipartisan work on crypto market-structure legislation, saying progress could attract further institutional capital. 

The Senate Agriculture Committee released draft text in November, and analysts expect more movement next year if the issue avoids partisan gridlock.

Although valuations have lagged sector growth this year, Grayscale said long-term fundamentals should eventually converge with market pricing. 

The firm emphasized that the most significant gains historically accrued to long-term holders.

Bitcoin Tests Key Levels As Traders Watch $93,000 Resistance

BTC Price Prediction as of December 2 (Source: TradingView)

Bitcoin on Tuesday bounced from the $84,000 support zone for the second time, reinforcing this level as the primary downside barrier. 

Buyers stepped in aggressively during the recent dip, yet the cryptocurrency still trades below a descending trendline near $92,000 to $93,000 that rejected multiple rallies in November.

A breakout above $93,000 would shift momentum upward, with follow-through levels at $97,300 and $100,000. 

The Supertrend indicator sits near $97,335 and the Parabolic SAR around $92,974, underscoring the importance of these areas for trend confirmation.

If Bitcoin loses the $84,000 floor, the next supports appear at $78,000 and $72,000. 

Market technicians warn that the gap between these levels could lead to a fast decline if selling intensifies.

Bitcoin remains confined between $84,000 and $93,000, with traders watching for a decisive move to determine the next phase.

Read Next:

Jim Cramer Notes ‘Horrible’ Bitcoin Start To December As BTC Falls By $4,000 In Minutes
Image: Shutterstock

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
2025-12-02 13:22 4mo ago
2025-12-02 08:11 4mo ago
Pi Network (PI) News Today: December 2nd cryptonews
PI
"PI is gearing up for something big. Stay tuned and position yourself," one X user speculated.

The team behind Pi Network rolled out multiple updates in the past few weeks, with some X users speculating that more major announcements are on the way.

While the project’s native token remains in green territory on a two-week scale, certain indicators suggest it might be gearing up for a short-term correction.

The Latest Endeavor and More
Towards the end of November, Pi Network’s team collaborated with CiDi Games (a gaming platform that builds Pi-integrated games millions of Pioneers can use). The partnership aims to broaden the real-world use cases of the PI token while unlocking new opportunities for the users.

In addition, Pi Network Ventures (the entity’s investment arm) backed CiDi games. The crypto project has supported the gaming sector over the last several months through initiatives such as hackathons, app incubation programs, and monetization via the Pi Ad Network. It also released FruityPi, which is a mobile game designed to give users a simple way to engage with the ecosystem while earning rewards.

According to X user Pi Network Academy, the Core Team could introduce another “huge” update before Christmas.

“It may be related to the V23 Protocol Upgrades & the much-awaited PiDex launch! PI is gearing up for something big. Stay tuned and position yourself,” the speculation reads.

Price Outlook
The collaboration with CiDi Games had a positive effect on PI, and despite the retreat over the past few days, its price is up approximately 3% on a two-week scale. This contrasts with the performance of many leading cryptocurrencies, which are well in the red within that timeframe. Bitcoin (BTC), for instance, has dropped by 4%, whereas Ethereum (ETH) has plunged by 8%.

PI Price, Source: CoinGecko
As of this writing, PI has a market cap of just south of $2 billion, making it the 60th-largest digital asset. Despite its minor resurgence, though, the token remains far from its glory days witnessed earlier in 2025.

You may also like:

Bitcoin (BTC) Plunges Before the FOMC Meeting, Pi Network (PI) Soars by 15%: Market Watch

Using ChatGPT to Understand When to Buy Pi Network (PI)

Back then, its price reached an all-time high of $3, whereas the capitalization exploded to roughly $13.5 billion.

What Are the Indicators Hinting?
More than 185 million PI tokens are scheduled for release in the next 30 days, which can be interpreted as a bearish signal. After all, the development will give some investors the chance to sell assets they have been waiting for some time. The record day is December 6, when 7.2 million tokens will be freed up.

PI Token Unlocks, Source: piscan.io
The shift toward exchanges may also spell bad news for the bulls. Almost 2.5 million tokens have been moved from self-custody to centralized platforms in the last 24 hours, a move often considered a pre-sale step. Of the 428.6 million coins held on exchanges, Gate.io controls the majority share.

Tags:
2025-12-02 13:22 4mo ago
2025-12-02 08:16 4mo ago
Bank of America backs 1–4% crypto allocation, opens door to Bitcoin ETFs cryptonews
BTC
More big-name financial institutions are opening the door to Bitcoin exposure, signaling a growing institutional appetite for regulated digital asset products.

Bank of America, the second-largest US bank, has reportedly recommended a 1–4% cryptocurrency allocation to its wealth management clients through the Merrill, Bank of America Private Bank and Merrill Edge platforms, according to a statement shared with Yahoo Finance on Tuesday.

“For investors with a strong interest in thematic innovation and comfort with elevated volatility, a modest allocation of 1% to 4% in digital assets could be appropriate,” said Chris Hyzy, chief investment officer at Bank of America Private Bank, in the statement shared with Yahoo.

Starting Jan. 5, the bank will enable its clients to gain access to four new Bitcoin (BTC) exchange-traded funds (ETFs), including the Bitwise Bitcoin ETF (BITB), Fidelity’s Wise Origin Bitcoin Fund (FBTC), Grayscale’s Bitcoin Mini Trust (BTC) and BlackRock’s iShares Bitcoin Trust (IBIT).

The development will enable the bank’s wealthiest clients to gain exposure to Bitcoin ETFs for the first time, which were only available upon request. Previously, the bank’s over 15,000 wealth advisers were unable to recommend any cryptocurrency investment products.

“Our guidance emphasizes regulated vehicles, thoughtful allocation, and a clear understanding of both the opportunities and risks,” added the bank’s chief investment officer.

The bank’s Bitcoin allocation recommendation is signaling a wider institutional appetite for regulated cryptocurrency investment products. It comes a day after Vanguard, the world’s second-largest asset manager, enabled crypto ETF trading for its clients, reversing its previous stance on digital asset ETFs.

Source: Eric Balchunas Cointelegraph has contacted Bank of America for more details on its crypto allocation recommendations.

Bank of America is the second-largest bank in the US with about $2.67 trillion in consolidated assets and over 3,600 branches, according to Forbes.

Largest US banks by assets. Source: Forbes.comBlackRock helped set the Bitcoin allocation playbookBlackRock, the world’s largest asset management firm, was the first large institution to recommend an up to 2% Bitcoin allocation to its clients, Cointelegraph reported in December 2024.

Around 1–2% is a “reasonable range for Bitcoin exposure,” which poses the “same share of overall portfolio risk” as a typical allocation to “the ‘magnificent 7’ group of mostly mega-cap tech stocks,” wrote BlackRock in a report at the time.

The “magnificent 7” refers to Amazon, Apple, Microsoft, Alphabet, Tesla, Meta and Nvidia.

In June, asset management firm Fidelity also recommended a 2% to 5% Bitcoin allocation, which was small enough to minimize the risk of a Bitcoin crash, but large enough to enjoy any upside from BTC’s inflationary hedge.

Earlier in October, Morgan Stanley also suggested a 2% to 4% allocation to crypto portfolios for investors and financial advisers, further signaling that large financial institutions are moving toward a shared playbook of modest, risk-managed exposure to digital assets.

Magazine: Mysterious Mr Nakamoto author — Finding Satoshi would hurt Bitcoin
2025-12-02 13:22 4mo ago
2025-12-02 08:16 4mo ago
Bank of America backs 1–4% crypto allocation, opens gates to Bitcoin ETFs cryptonews
BTC
More big-name financial institutions are opening the door to Bitcoin exposure, signaling a growing institutional appetite for regulated digital asset products.

Bank of America, the second-largest US bank, has reportedly recommended a 1–4% cryptocurrency allocation to its wealth management clients through the Merrill, Bank of America Private Bank and Merrill Edge platforms, according to a statement shared with Yahoo Finance on Tuesday.

“For investors with a strong interest in thematic innovation and comfort with elevated volatility, a modest allocation of 1% to 4% in digital assets could be appropriate,” said Chris Hyzy, chief investment officer at Bank of America Private Bank, in the statement shared with Yahoo.

Starting Jan. 5, the bank will enable its clients to gain access to four new Bitcoin (BTC) exchange-traded funds (ETFs), including the Bitwise Bitcoin ETF (BITB), Fidelity’s Wise Origin Bitcoin Fund (FBTC), Grayscale’s Bitcoin Mini Trust (BTC) and BlackRock’s iShares Bitcoin Trust (IBIT).

The development will enable the bank’s wealthiest clients to gain exposure to Bitcoin ETFs for the first time, which were only available upon request. Previously, the bank’s over 15,000 wealth advisers were unable to recommend any cryptocurrency investment products.

“Our guidance emphasizes regulated vehicles, thoughtful allocation, and a clear understanding of both the opportunities and risks,” added the bank’s chief investment officer.

The bank’s Bitcoin allocation recommendation is signaling a wider institutional appetite for regulated cryptocurrency investment products. It comes a day after Vanguard, the world’s second-largest asset manager, enabled crypto ETF trading for its clients, reversing its previous stance on digital asset ETFs.

Source: Eric Balchunas Cointelegraph has contacted Bank of America for more details on its crypto allocation recommendations.

Bank of America is the second-largest bank in the US with about $2.67 trillion in consolidated assets and over 3,600 branches, according to Forbes.

Largest US banks by assets. Source: Forbes.comBlackRock helped set the Bitcoin allocation playbookBlackRock, the world’s largest asset management firm, was the first large institution to recommend an up to 2% Bitcoin allocation to its clients, Cointelegraph reported in December 2024.

Around 1–2% is a “reasonable range for Bitcoin exposure,” which poses the “same share of overall portfolio risk” as a typical allocation to “the ‘magnificent 7’ group of mostly mega-cap tech stocks,” wrote BlackRock in a report at the time.

The “magnificent 7” refers to Amazon, Apple, Microsoft, Alphabet, Tesla, Meta and Nvidia.

In June, asset management firm Fidelity also recommended a 2% to 5% Bitcoin allocation, which was small enough to minimize the risk of a Bitcoin crash, but large enough to enjoy any upside from BTC’s inflationary hedge.

Earlier in October, Morgan Stanley also suggested a 2% to 4% allocation to crypto portfolios for investors and financial advisers, further signaling that large financial institutions are moving toward a shared playbook of modest, risk-managed exposure to digital assets.

Magazine: Mysterious Mr Nakamoto author — Finding Satoshi would hurt Bitcoin
2025-12-02 13:22 4mo ago
2025-12-02 08:19 4mo ago
I've Got Good Stuff Tonight About Where Bitcoin Can Hold: Jim Cramer cryptonews
BTC
Cover image via U.Today

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

After hitting an all-time high (ATH) of $126,198 in October, Bitcoin (BTC) has struggled to remain stable on the crypto market. Despite the continued fluctuations, host of Mad Money on CNBC Jim Cramer believes he knows the coin’s bottom support.

Skepticism grows over Cramer's "Inverse Indicator" reputationNotably, he plans to discuss possible support for the flagship crypto asset that has faced intense fluctuations within the last 60 days.

Since Nov. 13, Bitcoin has not been able to trade above the psychological $100,000 price level. This development has continued to bother market participants.

In Cramer’s opinion, Bitcoin is likely to find support at $80,000, meaning the current volatility will not breach this price level. 

I've got good stuff tonight about where Bitcoin can hold...Still noodling on physical a.i and the size of it v. the chatbot dogfight that transfixes everyone

— Jim Cramer (@jimcramer) December 2, 2025 The message has been received with mixed feelings from the crypto community.

It is worth mentioning that the Bitcoin community and traders alike are always skeptical of Cramer, given his historical record of making inverse predictions about Bitcoin. Many see his predictions as jinxing the flagship crypto coin.

For instance, in October 2025, barely one hour after Cramer predicted a push for crypto, Bitcoin suffered a 1.4% loss. 

When he stated that crypto assets were due for a gain, Bitcoin changed hands at $108,239. However, about 60 minutes later, the coin dropped to $106,700 in a move many dubbed the "Reverse Cramer."

A user, Nish Sachdev, expressed shock that Cramer was turning bullish on Bitcoin. 

Based on the antecedent, it implies that the coin could slip further below the predicted $80,000. Another member of the community suggested that Cramer should make a bearish prediction about the coin if he wants it to hold.

You Might Also Like

Analysts highlight bigger picture as volatility continuesMarket participants are uncertain how this will play out in terms of price outlook. 

As of press time, Bitcoin exchanged hands at $87,286.18, which is a 0.74% increase in the last 24 hours. The asset climbed from a low of $83,862.25 to its current level.

Trading volume has also jumped by 9.81% to $70.14 billion as traders continue to transact despite the volatility. With Cramer’s prediction hanging in the air, market observers are keen on seeing how the price will react.

Meanwhile, another analyst and legendary trader, Peter Brandt, believes that Bitcoin could still hit a target of $250,000. While he acknowledged that the coin might see deeper corrections, Brandt urged long-term investors not to panic, as a bull run is ahead.
2025-12-02 13:22 4mo ago
2025-12-02 08:20 4mo ago
Japan Turns to XRP Ledger as Backbone of Its Tokenized Economy cryptonews
XRP
Japan Contemplates Ripple’s XRPL for Zero-Knowledge ID, Paving the Way for a Tokenized EconomyMarket analyst Diana highlights a major milestone in Japan’s digital transformation: top sources confirm Ripple is building a zero-knowledge identity system on the XRP Ledger.

Therefore, this signals Japan may anchor national digital ID infrastructure on XRPL, reshaping finance, compliance, and the country’s emerging tokenized economy.

Zero-knowledge identity systems let users prove their identity without exposing sensitive data, boosting privacy, security, and compliance. By integrating this directly on XRPL, Ripple transforms its network from a payment platform into a robust digital infrastructure capable of powering government-grade identity solutions.

Japan is racing toward a tokenized economy, with government agencies and major banks testing blockchain-based asset issuance. 

Central to this vision is secure digital identity infrastructure, and Ripple’s involvement signals strong confidence in XRPL’s speed, efficiency, and compliance-ready framework.

If deployed nationally, Japan’s ZK identity system could become the backbone of its tokenized economy, unifying identity verification, KYC/AML compliance, and asset transfers on a single ledger, streamlining operations, boosting transparency, and enabling seamless interoperability across banks, government platforms, and private enterprises.

What does this mean? Well, analysts say this could cement XRPL as Japan’s foundational layer for digital assets, identity verification, and regulatory compliance. As one of the first national-scale deployments of zero-knowledge technology on a public blockchain, it sets a global precedent. 

Beyond Japan, a government-backed XRPL identity system could drive worldwide adoption of Ripple’s technology, boost investor confidence, and reinforce XRP’s role in a market increasingly defined by real-world utility over speculation.

ConclusionJapan’s adoption of a zero-knowledge identity system on the XRP Ledger signals a bold step toward a secure, efficient, and fully tokenized economy. 

Leveraging Ripple’s technology, the nation could set a global standard for blockchain-based digital identity, reshaping how citizens engage with financial systems, meet regulatory requirements, and access digital assets. This move elevates XRPL from a cryptocurrency network to a cornerstone of next-generation digital governance and economic innovation.
2025-12-02 13:21 4mo ago
2025-12-02 08:13 4mo ago
Herc Holdings Announces Proposed Private Offering of $1,200 Million of Senior Unsecured Notes stocknewsapi
HRI
BONITA SPRINGS, Fla.--(BUSINESS WIRE)--Herc Holdings, Inc. (NYSE: HRI) (“Herc Holdings” or the “Company”) today announced that it intends to offer $1,200 million aggregate principal amount of senior unsecured notes due 2031 and senior unsecured notes due 2034 (together, the “notes”) in a private offering exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), subject to market and other conditions. The terms of the notes will be determined at.
2025-12-02 13:21 4mo ago
2025-12-02 08:13 4mo ago
Victrex plc (VTXPF) Q4 2025 Earnings Call Transcript stocknewsapi
VTXPF
Victrex plc (OTCPK:VTXPF) Q4 2025 Earnings Call December 2, 2025 4:00 AM EST

Company Participants

Jakob Sigurdsson - CEO & Executive Director
Ian Melling - CFO & Executive Director

Conference Call Participants

Vanessa Jeffriess - Jefferies LLC, Research Division
Jens Lindqvist - Investec Bank plc, Research Division
Chetan Udeshi - JPMorgan Chase & Co, Research Division
Christian Bell - UBS Investment Bank, Research Division
Kevin Fogarty - Deutsche Bank AG, Research Division

Presentation

Jakob Sigurdsson
CEO & Executive Director

Those here in the room at JPMorgan in London and those joining us online as well to Victrex's full year results presentation for 2025. I'm Jakob Sigurdsson, CEO of Victrex.

Before we turn to the results summary in what has been a particularly challenging year for Victrex and of course, the chemical industry at large, I do want to highlight a couple of slides on Slides 2 and 3 in the presentation, and we'll call them out as we go along to put things in perspective. And I also tell you a little bit about how we are addressing the challenges we faced in FY '25 and continue to face, but underline that the long-term prospects and opportunity for Victrex remain very strong.

We are addressing these ongoing challenges, and we have been doing that in the past couple of years as well. We're also announcing a profit improvement plan today that builds on our self-help in 2025, but also leverages the recent investments in infrastructure, foundational investments like digital and other things to make us more efficient. We've now concluded those investments, as you clearly see in our CapEx profile and are now continuing to drive improvements on the back of these in many different areas.

But it is very important to note that we do remain a world leader in PEEK. Nobody has more

Recommended For You
2025-12-02 13:21 4mo ago
2025-12-02 08:13 4mo ago
Peer To Peer Network (PTOP) Retains Patent Infringement Counsel as PTOP Moves to Consolidate the Digital Business Card Industry and Enforce Its Intellectual Property Portfolio stocknewsapi
PTOP
The Company hires LSC IP to enforce its digital business card patents, drive consolidation, and offer rivals merger or licensing options.

Peer To Peer Network (OTC: PTOP) (“PTOP”) retains LSC IP to enforce its fully granted U.S. utility patents, marking the start of formal infringement actions.

Competitors are offered three choices: merge with PTOP, pay a licensing fee, or enter a royalty agreement.

PTOP aims to consolidate and redefine the digital business card industry, asserting its role as the original inventor and patent holder.

Boston, MA, December 2, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Peer To Peer Network, Inc. (OTC: PTOP), the original inventor of the digital business card, or “Electronic Interactive Business Card Mobile Software System With Customer Relationship Management Database” announced today that it has formally retained a law firm to enforce its fully granted U.S. Utility Patents 10,616,368 and 10,270,880. This strategic action positions PTOP to consolidate and lead a digital business card industry projected to reach $300 billion by 2032.

On November 25th, PTOP engaged LSC IP – Lambert, Shortell, Connaughton out of 100 Franklin Street, Boston, MA. Patent & Trademark Attorneys Serving Boston & Nashua New Hampshire – Lambert Shortell & Connaughton Law Firm LSC IP’s knowledgeable and results-oriented litigation team has a successful track record of handing complex intellectual property disputes in district courts, state courts, and the United States Patent & Trademark Office. When litigation and other IP enforcement controversies arise, LSC IP’s experienced trial lawyers are eager to protect and advance the interests of clients. Attorneys at the firm have litigated cases before juries and judges on behalf of and against individuals, small businesses, large corporations, individual states, and the United States of America. The firm’s current litigation team has a proven record in representing clients that range from large multinational companies to local businesses.

And the message is simple:
The era of infringing on MOBICARD’s patented technology is over.

Chairman & CEO Joshua Sodaitis, inventor of the patented electronic interactive business card system, stated that the company’s goal is not to eliminate competitors, but to unify the market under one powerful ecosystem.

“Having our competitors come under the tent of PTOP will not only enhance the brand but help them grow and prosper,” said Sodaitis.

“As the inventor of the digital business card, I would rather not put people out of business. I would rather they join our team, keep their organizations in place, and merge into Peer To Peer Network. Together, we can build a much stronger entity that benefits all founders involved.”

PTOP’s patents cover the foundational architecture that today powers nearly every digital business card platform. With enforcement actions now underway, the company intends to offer competitors three clear options:

Merge with PTOP
Pay a licensing fee
Enter a royalty agreement for every product sold

THE WRIGHT BROTHERS DID IT FIRST. NOW PTOP IS DOING IT.

The move echoes one of the most famous examples of U.S. patent enforcement—the Wright Brothers, who leveraged their aircraft control system patent to shape and protect the early aviation industry. Their success established the model for how strong utility patents can structure an entire market.

Just as the Wright Brothers shaped and controlled the aviation industry with a single groundbreaking patent, PTOP is preparing to reshape the entire digital business card landscape.

The comparison isn’t metaphorical — it’s tactical.

“Our utility patents are fully granted, enforceable, and extremely powerful.
We will use them exactly the way the Wright Brothers used theirs — with precision, confidence, and the intention to define an entire industry.” — Joshua Sodaitis, Chairman & CEO, Inventor of the Digital Business.

Sodaitis continued: “PTOP is committed to protecting the technology we developed while maintaining a collaborative posture toward companies currently infringing on our patents. We see clear pathways for constructive engagement, including licensing and partnership agreements.”

In a forceful message to the entire sector, Chairman & CEO Joshua Sodaitis made PTOP’s intentions crystal clear:

“We created this category. We own the patents. We set the rules. PTOP is here to unify the market — voluntarily or otherwise.”

And with global adoption accelerating, it’s fair to say:
PTOP’s consolidation plan may establish the company as the unavoidable, unshakeable market leader.

With the digital business card sector now scaling globally, some analysts believe the consolidation strategy may establish PTOP as the definitive industry leader. The company is getting ready to enter discussions with multiple competitors and expects additional updates in the coming weeks.

About Peer To Peer Network (PTOP)

Peer To Peer Network, Inc. is a publicly traded technology company (OTC: PTOP) and the original inventor of the digital business card. With multiple fully granted U.S. utility patents protecting its electronic interactive business card system, PTOP is positioned as the category creator and future consolidator of a projected $300 billion market. PTOP is headquartered in Massachusetts and operates the new AI division, PTOP Intelligence Labs.

Media Contact

Peer To Peer Network, Inc.
Investor Relations
Email: [email protected]
Website: www.PTOPnetwork.com

Source: Peer To Peer Network, Inc.
2025-12-02 13:21 4mo ago
2025-12-02 08:14 4mo ago
AGNC Investment: MBS Growth, Strong Dividend, Breakout Potential stocknewsapi
AGNC
Analyst’s Disclosure:I/we have a beneficial long position in the shares of AGNC either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-12-02 13:21 4mo ago
2025-12-02 08:15 4mo ago
Tego Cyber Reports First Quarter 2026 Financial Results stocknewsapi
TGCB
Record Revenue Growth, Strengthened Balance Sheet, and Breakthrough Ai Advancements Signal Accelerated Path Toward Profitability LAS VEGAS, NV / ACCESS Newswire / December 2, 2025 / Tego Cyber Inc. (OTCID:TGCB), a cybersecurity company delivering AI-driven threat intelligence and managed security solutions, today announced financial results for the three months ended September 30, 2025 ("Q1 2026"). Financial Highlights Revenue: Gross revenue increased from $107,481 for the three months ended September 30, 2024, to $555,994 for the same period in 2025 - representing more than 5x year-over-year growth.
2025-12-02 13:21 4mo ago
2025-12-02 08:15 4mo ago
GlobalTech Corporation Enters Into Definitive Agreement to Acquire Moda in Pelle, to Deliver a Boost to its Operations stocknewsapi
GLTK
RENO, Nev., Dec. 02, 2025 (GLOBE NEWSWIRE) -- GlobalTech Corporation (OTC:GTLK)(“GTC” or "GlobalTech”), a U.S. based technology holding company specializing in artificial intelligence (AI), big data, and emerging technologies, today announced the entry into a definitive purchase agreement to acquire a 51% interest in 123 Investments Limited d/b/a Moda in Pelle (MIP), a premium footwear brand established in 1975, with a strong presence in the UK market. MIP has remained at the cutting edge of technology deployment in its business operations and generated net revenues of approximately $37 million in its last fiscal year. The acquisition is expected to provide GTC with an additional revenue stream, significantly enhance its e-commerce capabilities through Thrivo AI activation in the MIP eco-system and strengthen its operational footprint in UK market. The Company expects the acquisition to close in the next 30 days, subject to customary closing conditions.

Dan Green, GlobalTech CEO commented, "We believe that the acquisition of MIP (which has been in business for 50 years) is a perfect fit for GlobalTech as we expect it to deliver substantial value creation, enhance our technology capabilities and provide direct access to the lucrative UK market. We further expect, Thrivo AI deployment in MIP’s operations will further boost business operations for GlobalTech and MIP. We look forward to collaborating with the 123 Investments team as we work to complete this exciting transaction.”

DETAILS OF THE TRANSACTION

GTC is acquiring a 51% stake in MIP in consideration for shares of common stock and Convertible Series A Preferred Stock of GTC. The Convertible Series A Preferred Stock, among other rights, convert into common stock of GlobalTech on the date that our common stock is uplisted to the NASDAQ Capital Market, as well as upon other conditions being met. The Series A Preferred Stock do not accrue any dividends.

123 Investments d/b/a Moda in Pelle (MIP) is a British footwear brand established in 1975. MIP has a strong presence in the UK market, offering high quality footwear and accessories through more than 40 retail stores and concessions and a strong online presence and independent stockists. For 50 years, MIP has been synonymous with elegance, blending British sophistication with Italian craftsmanship. Founded in Leeds by Stephen Buck, MIP’s journey began with a single store on Leed’s Bond Street. Today it remains rooted in Yorkshire, crafting stunning shoes, boots, bags, and accessories from the finest leathers.

More information regarding the transaction can be found in the Current Report on Form 8-K filed by GlobalTech with the Securities and Exchange Commission on December 2, 2025.

The Loev Law Firm, PC served as counsel to the Company in connection with the entry into the agreements with 123 Investments Limited.

About GlobalTech Corporation
GlobalTech Corporation is a U.S.-based technology holding company driving innovation across AI, big data, and emerging technologies. Through strategic partnerships, scalable platforms, and capital investments, GlobalTech empowers visionary companies and enterprises to transform industries and create exponential value in the digital economy.

For more information, visit: www.globaltechcorporation.com

Forward-Looking Statements
Certain of the matters discussed in this communication which are not statements of historical fact constitute forward-looking statements, that involve a number of risks and uncertainties. Words such as “strategy,” “expects,” “continues,” “plans,” “anticipates,” “believes,” “would,” “will,” “estimates,” “intends,” “projects,” “goals,” “targets” and other words of similar meaning are intended to identify forward-looking statements but are not the exclusive means of identifying these statements. Any statements made in this news release other than those of historical fact, about an action, event or development, are forward-looking statements. The important factors that may cause actual results and outcomes to differ materially from those contained in such forward-looking statements include, without limitation, our ability to close the acquisition of 123 Investments, the timing thereof, and potential lawsuits in connection therewith, our ability to consolidate 123 Investments’ operations into ours, our strategic plans, treasury management, expected benefits of integrating World Mobile Chain, our need for additional capital, the terms of such capital and potential dilution caused thereby; foreign currency exchange losses, fluctuations and translation risks related to our business in Pakistan; the international economic environment, geopolitical developments and unexpected global events which could cause our business to decline; investing in emerging markets, where our operations are located, is subject to greater risks than investing in more developed markets, including significant political, legal and economic risks; our revenue performance can be unpredictable by nature; we operate in highly competitive markets, which we expect only to become more competitive; we may be unable to keep pace with technological changes and evolving industry standards; we are exposed to cyber-attacks and other cybersecurity threats that may lead to compromised or inaccessible telecommunications, digital and financial services, and/or leaks or unauthorized processing of confidential information, and perceptions of such threats may cause customers to lose confidence in our services; the telecommunications industry is highly capital-intensive and requires substantial and ongoing expenditures of capital; we may also be subject to increases in license fees for some of our licenses or to obtain new licenses; the loss of important intellectual property rights, as well as third-party claims that we have infringed on their intellectual property rights; our substantial amounts of indebtedness and debt service obligations could materially decrease our cash flow, which could adversely affect our business and financial condition; our status as a controlled company; the fact that no active trading market for our common stock exists, and an active trading market may not develop or be sustained in the future; stockholders may be diluted significantly through our efforts to obtain financing and satisfy obligations through the issuance of additional shares of the common stock, including upon conversion of certain outstanding convertible notes; the telecommunications industry is a highly regulated industry, and we are subject to an extensive variety of laws and operate in uncertain judicial and regulatory environments, which may result in unanticipated outcomes that could harm our business; our operating subsidiaries are located in Pakistan, and their assets are in Pakistan, which may affect shareholder rights, including the ability to enforce civil liabilities under U.S. securities laws; we are, and may in the future be, involved in, associated with, or otherwise subject to legal liability in connection with disputes and litigation with regulators, competitors, and third parties; our licenses are granted for specific periods and may be suspended, revoked, or we may be unable to extend or replace these licenses upon expiration; we may be affected by economic downturns both in Pakistan and globally, changes in inflation and interest rates, tariffs, increased costs of borrowing associated therewith and potential declines in the availability of such funding; and risks relating to future divestitures, asset sales, joint ventures and acquisitions.

Other important factors that may cause actual results and outcomes to differ materially from those contained in the forward-looking statements included in this communication are described in GlobalTech’s publicly filed reports, including, but not limited to, GlobalTech’s Annual Report on Form 10-K for the year ended December 31, 2024 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, and future Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q. These reports are available at www.sec.gov. GlobalTech cautions that the foregoing list of important factors is not complete. All subsequent written and oral forward-looking statements attributable to GlobalTech or any person acting on behalf of GlobalTech are expressly qualified in their entirety by the cautionary statements referenced above. Other unknown or unpredictable factors also could have material adverse effects on GlobalTech’s future results. The forward-looking statements included in this press release are made only as of the date hereof. GlobalTech cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, GlobalTech undertakes no obligation to update these statements after the date of this release, except as required by law, and takes no obligation to update or correct information prepared by third parties that are not paid for by GlobalTech. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.

Contact:
Louie Toma
CORE IR
[email protected]
212-655-0924
2025-12-02 13:21 4mo ago
2025-12-02 08:15 4mo ago
Aeries Technology's Consulting-Led Automation Practice Delivers Measurable Impact stocknewsapi
AERT
Client Deploys Data Reconciliation Solution to Production

December 02, 2025 08:15 ET

 | Source:

Aeries Technology, Inc.

NEW YORK, Dec. 02, 2025 (GLOBE NEWSWIRE) --

Aeries Technology, Inc. (NASDAQ: AERT), a global leader in AI-powered business transformation and Global Capability Center (GCC) delivery, today announced that a leading digital enterprise platform provider has successfully deployed an automation-driven data reconciliation capability to production following a consulting-led digital transformation engagement.

As the client modernizes critical customer environments, high-volume data reconciliation across systems had become a major constraint on implementation speed and predictability. Aeries designed and delivered an automation layer that replaces months of manual work with governed, repeatable workflows. This resulted in implementation timelines being reduced by up to ~30 percent, while preserving data integrity, reducing operational risk, and accelerating migration cycles.

“Our teams now have a more predictable and consistent way to manage platform migrations,” the client said. “The automation has strengthened our deployment process and improved our confidence in delivering high-quality results.”

“This engagement highlights how our consulting-led transformation model and advanced automation capabilities help enterprises modernize core operations while unlocking higher-value work,” said Sachin Aghor, Chief Delivery Officer, Aeries Technology. “The swift progression from pilot to production reinforces the measurable value of our AI-led consulting practice.”

Industry analysts estimate the global data migration market will grow at a CAGR of 18.7%, reaching $33.6 billion by 2030. With automation and AI driving this expansion, Aeries’ consulting-led automation practice positions the company to capitalize on this significant market opportunity.

About Aeries Technology
Aeries Technology (NASDAQ: AERT) is a global leader in AI-enabled value creation, business transformation, and Global Capability Center (GCC) delivery for private-equity (PE) portfolio companies, supporting scalable, technology-driven execution. Founded in 2012, its commitment to workforce development has earned it the Great Place to Work Certification for two consecutive years.

Media Contact
[email protected]

Forward-Looking Statements
This press release contains forward-looking statements, including statements regarding product launches, leadership strategy, business expansion plans, initiatives, and operational transformation. These statements are subject to risks and uncertainties as detailed in the Company’s filings with the U.S. Securities and Exchange Commission, which are incorporated herein by reference. Actual results may differ materially. The Company disclaims any obligation to update forward-looking statements except as required by law.
2025-12-02 13:21 4mo ago
2025-12-02 08:15 4mo ago
Worthington Enterprises Schedules Fiscal Second Quarter 2026 Earnings Call for December 17 stocknewsapi
WOR
COLUMBUS, Ohio, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Worthington Enterprises Inc. (NYSE: WOR) will hold its quarterly earnings conference call Wednesday, December 17 at 8:30 a.m. ET. The company will discuss its fiscal second quarter results, which will be released after the market closes on December 16.

Please click here to register for the December 17 live audio webcast or visit IR.worthingtonenterprises.com. For those unable to listen live, a replay will be available in the Investors section of the company’s website approximately two hours after the completion of the call and will be archived for one year.

LIVE CONFERENCE CALL DETAILS

DateWednesday, December 17, 2025Webcast Link:https://events.q4inc.com/attendee/307975816Starting Time:8:30 a.m. ETConference ID:1777337Domestic Participants:888-330-3567   About Worthington Enterprises
Worthington Enterprises (NYSE: WOR) is a designer and manufacturer of market-leading brands that improve everyday life by elevating spaces and experiences. The company operates with two primary business segments: Building Products and Consumer Products. The Building Products segment includes heating and cooling, cooking, construction and water solutions, and building systems including HVAC components, architectural and acoustical grid ceilings and metal framing and accessories. The Consumer Products segment provides solutions for the tools, outdoor living and celebrations categories. Product brands within the Worthington Enterprises portfolio include Balloon Time®, Bernzomatic®, Coleman® (propane cylinders), CoMet®, Elgen, Garden Weasel®, General®, HALO™, Hawkeye™, LEVEL5 Tools®, Mag Torch®, NEXI™, Pactool International®, PowerCore™, Ragasco®, Well-X-Trol® and XLite™, among others.

Headquartered in Columbus, Ohio, Worthington Enterprises and its joint ventures employ approximately 6,000 people throughout North America and Europe.

Founded in 1955 as Worthington Industries, Worthington Enterprises follows a people-first Philosophy with earning money for its shareholders as its first corporate goal. Worthington Enterprises achieves this outcome by empowering its employees to innovate, thrive and grow with leading brands in attractive markets that improve everyday life. The company engages deeply with local communities where it has operations through volunteer efforts and The Worthington Companies Foundation, participates actively in workforce development programs and reports annually on its corporate citizenship and sustainability efforts. For more information, visit worthingtonenterprises.com.

Forward-Looking Statements
Statements by Worthington Enterprises that are not limited to historical information constitute “forward-looking statements” under federal securities laws. Forward-looking statements are subject to various risks, uncertainties and other factors that may cause actual results to differ materially from those expected by Worthington Enterprises. Readers should evaluate forward-looking statements in the context of such risks, uncertainties and other factors, many of which are described in Worthington Enterprises’ filings with the Securities and Exchange Commission (“SEC”). Forward-looking statements are qualified by the cautionary statements included in Worthington Enterprises’ SEC filings and other public communications. This press release speaks only as of the date hereof. Worthington Enterprises does not undertake any obligation to update or revise its forward-looking statements except as required by applicable law or regulation.

Sonya L. Higginbotham
Senior Vice President
Chief of Corporate Affairs, Communications and Sustainability
614.438.7391
[email protected]

Marcus A. Rogier
Treasurer and Investor Relations Officer
614.840.4663
[email protected]

200 Old Wilson Bridge Rd.
Columbus, Ohio 43085
WorthingtonEnterprises.com
2025-12-02 13:21 4mo ago
2025-12-02 08:15 4mo ago
ZenaTech Strengthens Drone as a Service Capabilities for Government and Aviation Markets Closing Acquisition of Smith Surveying Group in Jacksonville, Fla. stocknewsapi
ZENA
VANCOUVER, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology business solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, announces the completion of its acquisition of Smith Surveying Group LLC, a Jacksonville, Fla.-based land surveying and inspection firm with longstanding expertise and clients across municipal, aviation, and commercial markets. This 13th acquisition added to the Drone as a Service network strengthens the company’s capabilities to serve government and aviation markets in one of Florida’s fastest-growing metropolitan areas also known for its aviation and aerospace presence.

“Smith Surveying Group brings a long history and trusted relationships with Jacksonville area customer communities and offers enormous opportunities to deploy our Drone as a Service solutions across important verticals like transportation, public works, utilities, commercial, and coastal development survey markets,” said Shaun Passley, Ph.D., ZenaTech CEO. “The Florida aviation market is currently experiencing substantial investments in airport expansion and upgrades, which is driving demand for fast and efficient drone-based surveying and inspections, and we are ready to service these needs.”

Founded in 1988, Smith Surveying Group is an established presence in Jacksonville’s public sector and commercial markets across many of the region’s infrastructure, development and land-use projects. Along with the company’s recent acquisition of Jacksonville-based A&J Land Surveyors, Inc, also known for its expertise in aviation, infrastructure and utilities, ZenaTech’s Drone as a Service is well-positioned to capture a strong foothold in the region and beyond. 

Florida’s ongoing investment in aviation and infrastructure further accelerates this opportunity considering the state’s 2025/26 budget that dedicates over $345 million to airport modernization, expansion, and maintenance, driving strong demand for drone-based construction land surveys. Jacksonville’s complex coastal environment and expanding commercial corridors also create a growing need for environmental monitoring, hydrographic surveying, and construction oversight. This acquisition enables ZenaTech to broaden its service offerings, delivering advanced drone-based data across a diverse range of applications that support sustainable development and infrastructure resilience.

ZenaTech’s Drone as a Service (DaaS) offering provides business and government clients flexible and on-demand or subscription-based access to drone services for surveying, inspection, maintenance, power washing, inventory management, and precision agriculture and other services, without the capital costs or operational burdens of ownership. By acquiring established, profitable service companies ready for drone innovation, ZenaTech is building a global, multi-service DaaS network anchored by existing customers and recurring revenue. 

About ZenaTech

ZenaTech (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) is a technology company specializing in AI drone, Drone as a Service (DaaS), enterprise SaaS and Quantum Computing solutions for mission-critical business applications. Since 2017, the Company has leveraged its software development expertise and grown its drone design and manufacturing capabilities through ZenaDrone, to innovate and improve customer inspection, monitoring, safety, security, compliance, and surveying processes. With enterprise software customers using branded solutions in law enforcement, government, and industrial sectors, and drones being implemented in these plus agriculture, defense, and logistics sectors, ZenaTech’s portfolio of solutions helps drive exceptional operational efficiencies, speed, and accuracy. The Company operates through global offices in North America, Europe, Taiwan, and UAE, and is growing its US DaaS business and network of locations through acquisitions.

About ZenaDrone

ZenaDrone, a wholly owned subsidiary of ZenaTech, designs and manufactures autonomous business drone solutions that can incorporate machine learning software, AI, predictive modeling, Quantum Computing, and other software and hardware innovations. Created to revolutionize the hemp farming sector, its specialization has grown to the development of multifunctional drone solutions designed for industrial inspections, monitoring, maintenance, precision agriculture, process automation, and defense applications. Currently, the ZenaDrone 1000 drone is used for crop management applications in agriculture and has been used for critical field cargo applications in the defense sector, the IQ Nano indoor drone is used for inventory management and security in the warehouse and logistics sectors, and the IQ Square is an outdoor drone designed for land surveys and inspections use in commercial and defense sectors.

Contacts for more information:

Company, Investors, and Media:

Linda Montgomery

ZenaTech

312-241-1415

[email protected]

Investors:

Michael Mason

CORE IR

[email protected]

Safe Harbor

This press release and related comments by management of ZenaTech, Inc. include “forward-looking statements” within the meaning of U.S. federal securities laws and applicable Canadian securities laws. These forward-looking statements are subject to the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. This forward-looking information relates to future events or future performance of ZenaTech and reflects management’s expectations and projections regarding ZenaTech’s growth, results of operations, performance, and business prospects and opportunities. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management. In some cases, forward-looking information can be identified by terminology such as “may”, “will”, “should”, “expect”, “plan”, “anticipate”, “aim”, “seek”, “is/are likely to”, “believe”, “estimate”, “predict”, “potential”, “continue” or the negative of these terms or other comparable terminology intended to identify forward-looking statements. Forward-looking information in this document includes, but is not limited to ZenaTech’s expectations regarding its revenue, expenses, production, operations, costs, cash flows, and future growth; expectations with respect to future production costs and capacity; ZenaTech's ability to deliver products to the market as currently contemplated, including its drone products including ZenaDrone 1000 and IQ Nano; ZenaTech’s anticipated cash needs and it’s needs for additional financing; ZenaTech’s intention to grow the business and its operations and execution risk; expectations with respect to future operations and costs; the volatility of stock prices and market conditions in the industries in which ZenaTech operates; political, economic, environmental, tax, security, and other risks associated with operating in emerging markets; regulatory risks; unfavorable publicity or consumer perception; difficulty in forecasting industry trends; the ability to hire key personnel; the competitive conditions of the industry and the competitive and business strategies of ZenaTech; ZenaTech’s expected business objectives for the next twelve months; ZenaTech’s ability to obtain additional funds through the sale of equity or debt commitments; investment capital and market share; the ability to complete any contemplated acquisitions; changes in the target markets; market uncertainty; ability to access additional capital, including through the listing of its securities in various jurisdictions; management of growth (plans and timing for expansion); patent infringement; litigation; applicable laws, regulations, and any amendments affecting the business of ZenaTech. 
2025-12-02 13:21 4mo ago
2025-12-02 08:15 4mo ago
AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers stocknewsapi
ABBV
Data being presented showcases AbbVie's breadth and depth of research across a range of therapeutic modalities such as T-Cell Engagers, BCL-2 Inhibitors and Antibody-Drug Conjugates for a spectrum of difficult-to-treat blood cancers

, /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced it will unveil new data at the 2025 American Society of Hematology (ASH) Congress, showcasing continued advances in research across multiple blood cancers including — multiple myeloma (MM), follicular lymphoma (FL), chronic lymphocytic leukemia (CLL), diffuse large B-cell lymphoma (DLBCL), acute myeloid leukemia (AML) and amyloidosis (AL). Data across AbbVie's blood cancer portfolio will be featured in multiple oral and poster presentations including investigational compounds etentamig (ABBV-383) and PVEK (pivekimab sunirine), as well as approved therapies EPKINLY® (epcoritamab-bysp) and VENCLEXTA® (venetoclax). 

"These ASH presentations reinforce AbbVie's leadership in advancing the potential next wave of blood cancer innovation, with clinical data that highlight our commitment to raising the standard of care," said Daejin Abidoye, vice president, therapeutic area head, oncology, solid tumor and hematology at AbbVie. "The data also highlights the depth and diversity of our pipeline and portfolio of approved medicines spanning across T-cell engagers, BCL-2 Inhibitors and ADCs, all designed to address the heterogeneity of blood cancers for a range of patients."

Key data from epcoritamab, venetoclax-based treatments, etentamig and PVEK to be highlighted as oral presentations demonstrate promising efficacy, durable responses, and safety profiles across multiple hematologic malignancies and lines of therapy:

Fixed-Duration epcoritamab (CD20×CD3 Bispecific T-Cell Engager) in combination with rituximab and lenalidomide (R2) in Relapsed or Refractory FL

Results from the randomized phase 3 trial EPCORE FL-1 (NCT05409066) of fixed-duration epcoritamab, in combination with R2 for patients with relapsed or refractory (R/R) FL (n=243) demonstrate significantly superior progression-free survival (PFS) and overall response rates (ORR) compared to standard of care R2 (n=245).1
The study showed that treatment with epcoritamab + R2 (E+R2) reduced the risk of disease progression or death by 79% compared to standard of care R2, with significantly longer PFS in patients treated with E+R2 vs. those treated with R2 (hazard ratio [HR] 0.21; 95% CI: 0.13, 0.33; P<.0001). A preplanned interim analysis was conducted after the first 232 patients achieved 12 months of follow-up post-randomization, and the ORR was significantly improved in patients treated with E+R2 (95.7% [95% CI: 90.2, 98.6]) vs R2 (81.0% [95% CI: 72.7, 87.7]; P<.0001.1 
Among patients who were treated with E+R2, 74.5% achieved a complete response (CR) (n=95% CI: 68.5, 79.8) compared to a 43.3% CR rate among patients treated with R2 (n=95% CI: 37.0, 49.7).1
Grade 3/4 treatment emergent adverse events (TEAEs) were reported in 88.1% of patients receiving E+R2 vs 62.2% with R2, the difference being primarily driven by higher rates of neutropenia (66.3% vs 37.8%) and infections (29.2% vs 13.4%).1 In the E+R2 group, CRS events were at a low grade, and all resolved eventually.1 Recently, EPKINLY in combination with R2 was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with R/R FL.2

Fixed-Duration Venetoclax (BCL-2 Inhibitor) Regimens in Previously Untreated CLL

Interim data will be showcased from the randomized, Phase 3 CLL17 trial (NCT04608318) conducted and presented by the German CLL Study Group (GCLLSG) comparing continuous ibrutinib (I) monotherapy (n=301) to fixed-duration venetoclax plus obinutuzumab (VO; n=303) and venetoclax plus ibrutinib (VI; n=305) for patients with previously untreated CLL.3 The study was designed to test non-inferiority of VO vs I and VI vs I.3
After a median follow-up of 34.2 months, the study met non-inferiority endpoints for the VO arm compared to I arm (HR 0.87, type-I-error adjusted CI [98.3%] 0.54-1.41) and for VI arm compared to I arm (HR 0.84, type-I-error adjusted CI [98.0%] 0.53-1.32).3 The 3-year PFS for VO, I and IV arms were 81.1%, 81.0% and 79.4% respectively.3
The most frequent adverse events (AEs) were infections and infestations (VO: 76.3%, VI: 80.2%, I: 79.9%), gastrointestinal disorders (VO: 59.7%, VI: 74.3%, I: 63.4%), and blood and lymphatic system disorders (VO: 59.0%, VI: 42.9%, I: 28.5%).3
Venetoclax plus ibrutinib is an investigational combination not approved by the FDA.

Etentamig (Bispecific T-Cell Engager) in R/R MM and AL

Results from a Phase 1b multi-arm, open-label study evaluating etentamig, a BCMAxCD3 bispecific T-cell engager, (NCT05259839) combined with pomalidomide and dexamethasone (POM+DEX) in 85 heavily pretreated (at least 3 prior lines of therapy) R/R multiple myeloma patients will be presented.4
Preliminary data from the dose escalation portion of the study (n=82) highlight that etentamig in combination with POM+DEX achieved an ORR of 81% and a very good partial response or better (≥VGPR) of 72% at median follow-up of 23 months (range: 1-33 months).4 In this heavily pretreated population, duration of response (DoR) were not reached at time of analysis.
Most common grade 3/4 AEs were neutropenia (78%), anemia (28%) and thrombocytopenia (22%).4 Overall, these data support further exploration of the regimen in a randomized Phase 3 study.4
Additional preliminary data from the dose escalation study with etentamig monotherapy in R/R light chain AL will be showcased as an oral presentation. (NCT06158854)

PVEK (Antibody Drug Conjugate) in Newly Diagnosed AML

PVEK is a first-in-class antibody-drug conjugate comprised of a high-affinity anti-CD123 antibody and an indolinobenzodiazepine pseudodimer (IGN) payload. An oral presentation will showcase data from the dose expansion part of an open-label Phase 1b/2 study of PVEK combined with venetoclax and azacitidine (VEN + AZA) in newly diagnosed, CD123-positive AML patients (n=49) who are unfit for intensive chemotherapy (NCT04086264).5 The results show high CR rates of 63.3% with PVEK+VEN+AZA.5 The most common TEAEs (any grade) were neutropenia and thrombocytopenia (both at 69%), constipation (61%) and peripheral edema (51%).5 These data highlight the need to further evaluate this regimen in a randomized trial.5
A Biologics License Application (BLA) for PVEK was recently submitted to the FDA seeking approval for patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), a rare blood cancer.6   

Details on key presentations at the ASH 2025 Congress are available below and the full abstracts are available here:  

Title

Date/Time

Session

Abstract / Presentation Number

Epcoritamab + R-mini-CHOP results in 2-year remissions and high MRD negativity rates in elderly patients with newly diagnosed DLBCL: Results from the EPCORE NHL-2 trial

Saturday, December 6, 10:15 AM – 10:30 AM ET

Oral Abstract Session

Presentation ID 64

Room

OCCC - Tangerine Ballroom F2

Session 629: Aggressive Lymphomas, Immunotherapy including Bispecific Antibodies: Overcoming Barriers in Frontline Therapy: Bispecific Antibodies for Older Adults with DLBCL

3828

Etentamig plus pomalidomide-dexamethasone combination therapy in relapsed or refractory multiple myeloma: A phase 1b dose-escalation and safety expansion study

Saturday, December 6, 02:00 – 02:15 PM ET

Oral Abstract Session

Presentation ID 247

Room

OCCC - West Hall D1

Session 654: Multiple Myeloma: Pharmacologic Therapies: Advances in Treatment Strategies for Relapsed/Refractory Multiple Myeloma

1875

Subgroup analyses from the randomized, Phase 3 VERONA study of venetoclax with azacitidine (Ven+Aza) versus placebo with azacitidine (Pbo+Aza) in patients with treatment-naïve, intermediate and higher-risk Myelodysplastic Syndromes (HR MDS) 

Saturday, December 6, 02:00 – 02:15 PM ET

Oral Abstract Session

Presentation ID 235

Room OCCC - Valencia Room W415BC

Session 637: Myelodysplastic Syndromes: Clinical and Epidemiological: Treatment Advances in Higher Risk Myelodysplastic Syndromes

13272

Rituximab and epcoritamab as first-line therapy for patients with high-tumor burden follicular lymphoma: Results of a multicenter phase II trial

Sunday, December 7, 09:45 AM – 10:00 AM ET

Oral Abstract Session

Presentation ID 464

Room

OCCC - West Hall D2

Session 623: Mantle Cell, Follicular, Waldenstrom's, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological - Immunotherapies for Follicular Lymphoma

11119

Primary Phase 3 results from the epcore FL-1 trial of epcoritamab with rituximab and lenalidomide (R2) versus R2 for relapsed or refractory follicular lymphoma

Sunday, December 7, 10:15 – 10:30 AM ET

Oral Abstract Session

Presentation ID 466

Room

OCCC - West Hall D2

Session 623: Mantle Cell, Follicular, Waldenstrom's, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological - Immunotherapies for Follicular Lymphoma

244

Fixed-duration versus continuous targeted treatment for previously untreated chronic lymphocytic leukemia: Results from the randomized CLL17 trial

Sunday, December 7, 02:05 – 02:20 PM ET

Marquee Sessions

Presentation ID 1

OCCC - West Hall D2

Plenary Scientific Session

2071

Results from paradigm - a phase 2 randomized multi-center study comparing azacitidine and venetoclax to conventional induction chemotherapy for newly diagnosed fit adults with acute myeloid leukemia

Sunday, December 7, 03:45 – 04:00 PM ET

Marquee Sessions

Presentation ID 6

Room

OCCC - West Hall D2

Session: Plenary Scientific Session

8236

Phase 1/2 dose escalation and expansion study of etentamig in patients with relapsed or refractory light chain amyloidosis

Sunday, December 7, 04:45 – 05:00 PM ET

Oral Abstract Session

Presentation ID 692

OCCC - Tangerine Ballroom F1

Session 652: MGUS, Amyloidosis, and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological: New therapies and treatment goals for AL amyloidosis

10869

Efficacy and safety of pivekimab sunirine in combination with venetoclax plus azacitidine in unfit patients with newly diagnosed Acute Myeloid Leukemia

Sunday, December 7, 05:00 PM – 05:15 PM ET

Oral Abstract Session

Presentation ID 651

Room

OCCC - Chapin Theater (W320)

Session 616: Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Immunotherapy and chemotherapy combinations in AML

2524

Long-term immune reconstitution and final 1-year follow-up after fixed-duration venetoclax-obinutuzumab (VenO) in first-line (1L) chronic lymphocytic leukemia (CLL): Results from the Phase III CRISTALLO trial

Sunday, December 7, 05:15 – 05:30 PM ET

Oral Abstract Session

Presentation ID 682

Room OCCC – W224ABEF

Session 642: Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Frontline Treatment Strategies for CLL

2333

Efficacy of 2nd-line treatment in CLL after venetoclax-based 1st-line treatment: Results from the GAIA/CLL13 trial

Monday, December 8, 11:00 – 11:15 AM ET

Oral Abstract Session

Presentation ID 795

Room OCCC - W224ABEF

Session 642: Chronic Lymphocytic Leukemia: Clinical and Epidemiological: MRD Guided Therapy and Emergence of Resistance

7495

Epcoritamab combinations demonstrate promising efficacy in patients (pts) with Richter transformation (RT): First results from arms 2B (epcor + lenalidomide [LEN]) and 2C (epcor + R-CHOP) of the phase 1b/2 EPCORE CLL-1 trial

Monday, December 8, 04:30 – 04:45 PM ET

Oral Abstract Session

Presentation ID 1015

Room

OCCC - Tangerine Ballroom F1

Session 629: Aggressive Lymphomas, Immunotherapy including Bispecific Antibodies: Improving Outcomes in Rare Large Cell Lymphomas

2683

Epcoritamab monotherapy demonstrates promising efficacy in patients with Richter transformation (RT): 2-year follow-up results from arm 2A of the phase 1b/2 EPCORE CLL-1 trial

Monday, December 8, 04:30 PM – 04:45 PM ET

Oral Abstract Session

Presentation ID 1017

Room OCCC - Tangerine Ballroom F1

Session 629: Aggressive Lymphomas, Immunotherapy including Bispecific Antibodies: Improving Outcomes in Rare Large Cell Lymphomas

7534

Sustained remissions beyond 4 years with epcoritamab monotherapy: Long term follow-up results from the pivotal EPCORE NHL-1 trial in patients with relapsed or refractory large B-cell lymphoma

Monday, December 8, 06:00 PM - 08:00 PM EST

Poster Abstract Session

Presentation ID 5513

Room

OCCC - West Halls B3-B4

Session 629: Aggressive Lymphomas, Immunotherapy including Bispecific Antibodies: Poster III

7543

Etentamig (ABBV-383) and PVEK are investigational medicines and are not approved by any health authorities worldwide. The safety and efficacy of these investigational medicines are under evaluation as part of ongoing clinical studies. EPKINLY® (epcoritamab-bysp) and VENCLEXTA® (venetoclax) are approved medicines being investigated for additional uses. Safety and efficacy have not been established for these unapproved additional uses.

EPKINLY®/TEPKINLY® (epcoritamab) is being co-developed by Genmab and AbbVie as part of the companies' oncology collaboration. The companies share commercial responsibilities in the U.S. and Japan, with AbbVie responsible for further global commercialization. 

VENCLEXTA®/VENCLYXTO® (venetoclax) is being developed by AbbVie and Roche. It is jointly commercialized by AbbVie and Genentech, a member of the Roche Group, in the U.S. and by AbbVie outside of the U.S.

Additional information on AbbVie clinical trials is available at https://www.clinicaltrials.gov/. 

U.S. Prescribing Information for AbbVie Medicines

EPKINLY® (epcoritamab-bysp) U.S. INDICATIONS & IMPORTANT SAFETY INFORMATION 

What is EPKINLY?
EPKINLY is a prescription medicine used to treat adults with:

certain types of diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma that has come back (relapsed) or that did not respond (refractory), after 2 or more treatments.

EPKINLY for the treatment of DLBCL is approved based on patient response data. Studies are ongoing to confirm the clinical benefit of EPKINLY.

follicular lymphoma (FL) that has come back or that did not respond to previous treatment, together with lenalidomide and rituximab
follicular lymphoma (FL) that has come back or that did not respond after receiving 2 or more treatments.

It is not known if EPKINLY is safe and effective in children.

Important Warnings—EPKINLY can cause serious side effects, including:

Cytokine release syndrome (CRS), which is common during treatment with EPKINLY and can be serious or lead to death. To help reduce your risk of CRS, you will receive EPKINLY on a step-up dosing schedule (when you receive 2 or 3 smaller step-up doses of EPKINLY before your first full dose during your first cycle of treatment), and you may also receive other medicines before and for 3 days after receiving EPKINLY. If your dose of EPKINLY is delayed for any reason, you may need to repeat the step-up dosing schedule.
Neurologic problems that can be serious, and can be life-threatening, and lead to death. Neurologic problems may happen days or weeks after you receive EPKINLY.

People with DLBCL or high-grade B-cell lymphoma should be hospitalized for 24 hours after receiving their first full dose of EPKINLY on Day 15 of Cycle 1 due to the risk of CRS and neurologic problems.

People with follicular lymphoma (FL) may need to be hospitalized after receiving their first full dose of EPKINLY on Day 22 of Cycle 1 due to the risk of CRS.

Tell your healthcare provider or get medical help right away if you develop a fever of 100.4°F (38°C) or higher; dizziness or lightheadedness; trouble breathing; chills; fast heartbeat; feeling anxious; headache; confusion; shaking (tremors); problems with balance and movement, such as trouble walking; trouble speaking or writing; confusion and disorientation; drowsiness, tiredness or lack of energy; muscle weakness; seizures; or memory loss. These may be symptoms of CRS or neurologic problems. If you have any symptoms that impair consciousness, do not drive or use heavy machinery or do other dangerous activities until your symptoms go away.

EPKINLY can cause other serious side effects, including:

Infections that may lead to death. Your healthcare provider will check you for signs and symptoms of infection before and during treatment and treat you as needed if you develop an infection. You should receive medicines from your healthcare provider before you start treatment to help prevent infection. Tell your healthcare provider right away if you develop any symptoms of infection during treatment, including fever of 100.4°F (38°C) or higher, cough, chest pain, tiredness, shortness of breath, painful rash, sore throat, pain during urination, feeling weak or generally unwell, or confusion.
Low blood cell counts, which can be serious or severe. Your healthcare provider will check your blood cell counts during treatment. EPKINLY may cause low blood cell counts, including low white blood cells (neutropenia and lymphopenia), which can increase your risk for infection; low red blood cells (anemia), which can cause tiredness and shortness of breath; and low platelets (thrombocytopenia), which can cause bruising or bleeding problems.

Your healthcare provider will monitor you for symptoms of CRS, neurologic problems, infections, and low blood cell counts during treatment with EPKINLY. Your healthcare provider may temporarily stop or completely stop treatment with EPKINLY if you develop certain side effects.

Before you receive EPKINLY, tell your healthcare provider about all your medical conditions, including if you have an infection, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. If you receive EPKINLY while pregnant, it may harm your unborn baby. If you are a female who can become pregnant, your healthcare provider should do a pregnancy test before you start treatment with EPKINLY and you should use effective birth control (contraception) during treatment and for 4 months after your last dose of EPKINLY. Tell your healthcare provider if you become pregnant or think that you may be pregnant during treatment with EPKINLY. Do not breastfeed during treatment with EPKINLY and for 4 months after your last dose of EPKINLY.

The most common side effects of EPKINLY when used alone in DLBCL or high-grade B-cell lymphoma or FL include CRS, injection site reactions, tiredness, muscle and bone pain, fever, diarrhea, COVID-19, rash, and stomach-area (abdominal) pain. The most common severe abnormal laboratory test results with EPKINLY when used alone include decreased white blood cells, decreased red blood cells, and decreased platelets.

The most common side effects of EPKINLY when used together with lenalidomide and rituximab in FL include rash, upper respiratory tract infections, tiredness, injection site reactions, constipation, diarrhea, CRS, pneumonia, COVID-19, and fever. The most common severe abnormal laboratory test results with EPKINLY when used together with lenalidomide and rituximab include decreased white blood cells and decreased platelets.

These are not all of the possible side effects of EPKINLY. Call your doctor for medical advice about side effects.

You are encouraged to report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch or to Genmab US, Inc. at 1-855-4GENMAB (1-855-443-6622).

Please click here for the Full Prescribing Information and Medication Guide.

VENCLEXTA® (venetoclax) U.S. Uses and Important Safety Information

Uses
VENCLEXTA is a prescription medicine used:

to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
in combination with azacitidine, or decitabine, or low-dose cytarabine to treat adults with newly diagnosed acute myeloid leukemia (AML) who:
  ‒ are 75 years of age or older, or
  ‒ have other medical conditions that prevent the use of standard chemotherapy.

It is not known if VENCLEXTA is safe and effective in children.

Important Safety Information

What is the most important information I should know about VENCLEXTA?

VENCLEXTA can cause serious side effects, including:

Tumor lysis syndrome (TLS). TLS is caused by the fast breakdown of cancer cells. TLS can cause kidney failure, the need for dialysis treatment, and may lead to death. Your healthcare provider will do tests to check your risk of getting TLS before you start taking VENCLEXTA. You will receive other medicines before starting and during treatment with VENCLEXTA to help reduce your risk of TLS. You may also need to receive intravenous (IV) fluids into your vein. Your healthcare provider will do blood tests to check for TLS when you first start treatment and during treatment with VENCLEXTA. It is important to keep your appointments for blood tests. Tell your healthcare provider right away if you have any symptoms of TLS during treatment with VENCLEXTA, including fever, chills, nausea, vomiting, confusion, shortness of breath, seizures, irregular heartbeat, dark or cloudy urine, unusual tiredness, or muscle or joint pain.

Drink plenty of water during treatment with VENCLEXTA to help reduce your risk of getting TLS. Drink 6 to 8 glasses (about 56 ounces total) of water each day, starting 2 days before your first dose, on the day of your first dose of VENCLEXTA, and each time your dose is increased.

Your healthcare provider may delay, decrease your dose, or stop treatment with VENCLEXTA if you have side effects. When restarting VENCLEXTA after stopping for 1 week or longer, your healthcare provider may again check for your risk of TLS and change your dose.

Who should not take VENCLEXTA?

Certain medicines must not be taken when you first start taking VENCLEXTA and while your dose is being slowly increased because of the risk of increased TLS.

Tell your healthcare provider about all the medicines you take, including prescription and over-the- counter medicines, vitamins, and herbal supplements. VENCLEXTA and other medicines may affect each other causing serious side effects.
Do not start new medicines during treatment with VENCLEXTA without first talking with your healthcare provider.

Before taking VENCLEXTA, tell your healthcare provider about all of your medical conditions, including if you:

have kidney or liver problems.
have problems with your body salts or electrolytes, such as potassium, phosphorus, or calcium.
have a history of high uric acid levels in your blood or gout.
are scheduled to receive a vaccine. You should not receive a "live vaccine" before, during, or after treatment with VENCLEXTA, until your healthcare provider tells you it is okay. If you are not sure about the type of immunization or vaccine, ask your healthcare provider. These vaccines may not be safe or may not work as well during treatment with VENCLEXTA.
are pregnant or plan to become pregnant. VENCLEXTA may harm your unborn baby. If you are able to become pregnant, your healthcare provider should do a pregnancy test before you start treatment with VENCLEXTA, and you should use effective birth control during treatment and for 30 days after the last dose of VENCLEXTA. If you become pregnant or think you are pregnant, tell your healthcare provider right away.
are breastfeeding or plan to breastfeed. It is not known if VENCLEXTA passes into your breast milk. Do not breastfeed during treatment with VENCLEXTA and for 1 week after the last dose.

What should I avoid while taking VENCLEXTA?

You should not drink grapefruit juice or eat grapefruit, Seville oranges (often used in marmalades), or starfruit while you are taking VENCLEXTA. These products may increase the amount of VENCLEXTA in your blood.

What are the possible side effects of VENCLEXTA?

VENCLEXTA can cause serious side effects, including:

Low white blood cell counts (neutropenia). Low white blood cell counts are common with VENCLEXTA, but can also be severe. Your healthcare provider will do blood tests to check your blood counts during treatment with VENCLEXTA and may pause dosing.
Infections. Death and serious infections such as pneumonia and blood infection (sepsis) have happened during treatment with VENCLEXTA. Your healthcare provider will closely monitor and treat you right away if you have a fever or any signs of infection during treatment with VENCLEXTA.

Tell your healthcare provider right away if you have a fever or any signs of an infection during treatment with VENCLEXTA.

The most common side effects of VENCLEXTA when used in combination with obinutuzumab or rituximab or alone in people with CLL or SLL include low white blood cell counts; low platelet counts; low red blood cell counts; diarrhea; nausea; upper respiratory tract infection; cough; muscle and joint pain; tiredness; and swelling of your arms, legs, hands, and feet.

The most common side effects of VENCLEXTA in combination with azacitidine or decitabine or low-dose cytarabine in people with AML include nausea; diarrhea; low platelet count; constipation; low white blood cell count; fever with low white blood cell count; tiredness; vomiting; swelling of arms, legs, hands, or feet; fever; infection in lungs; shortness of breath; bleeding; low red blood cell count; rash; stomach (abdominal) pain; infection in your blood; muscle and joint pain; dizziness; cough; sore throat; and low blood pressure.

VENCLEXTA may cause fertility problems in males. This may affect your ability to father a child. Talk to your healthcare provider if you have concerns about fertility.

These are not all the possible side effects of VENCLEXTA. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please click here for the Full Prescribing Information and Medication Guide. 

Globally, prescribing information varies; refer to the individual country product labels for complete information.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology, neuroscience and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter) and YouTube. 

About AbbVie in Oncology

AbbVie is committed to elevating standards of care and bringing transformative therapies to patients worldwide living with difficult-to-treat cancers. We are advancing a dynamic pipeline of investigational therapies across a range of cancer types in both blood cancers and solid tumors. We are focusing on creating targeted medicines that either impede the reproduction of cancer cells or enable their elimination. We achieve this through various, targeted treatment modalities and biology interventions, including small molecule therapeutics, antibody-drug conjugates (ADCs), immuno-oncology-based therapeutics, multispecific antibody and novel CAR-T platforms. Our dedicated and experienced team joins forces with innovative partners to accelerate the delivery of potential breakthrough medicines.

Today, our expansive oncology portfolio comprises approved and investigational treatments for a wide range of blood cancers and solid tumors. We are evaluating more than 35 investigational medicines in multiple clinical trials across some of the world's most widespread and debilitating cancers. As we work to have a remarkable impact on people's lives, we are committed to exploring solutions to help patients obtain access to our cancer medicines. For more information, please visit http://www.abbvie.com/oncology.

Forward-Looking Statements

Some statements in this news release are, or may be considered, forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "anticipate," "project" and similar expressions and uses of future or conditional verbs, generally identify forward-looking statements. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. Such risks and uncertainties include, but are not limited to, challenges to intellectual property, competition from other products, difficulties inherent in the research and development process, adverse litigation or government action, changes to laws and regulations applicable to our industry, the impact of global macroeconomic factors, such as economic downturns or uncertainty, international conflict, trade disputes and tariffs, and other uncertainties and risks associated with global business operations. Additional information about the economic, competitive, governmental, technological and other factors that may affect AbbVie's operations is set forth in Item 1A, "Risk Factors," of AbbVie's 2024 Annual Report on Form 10-K, which has been filed with the Securities and Exchange Commission, as updated by its Quarterly Reports on Form 10-Q and in other documents that AbbVie subsequently files with the Securities and Exchange Commission that update, supplement or supersede such information. AbbVie undertakes no obligation, and specifically declines, to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law. 

References:

Falchi L, Nijland M, Huang H, et al. Primary Phase 3 results from the epcore FL-1 trial of epcoritamab with rituximab and lenalidomide (R2) versus R2 for relapsed or refractory follicular lymphoma. Abstract 224 presented at the American Society of Hematology Congress 2025. Orlando, Florida. 
EPKINLY (epcoritamab-bysp) [package insert]. Copenhagen, Denmark: Genmab, 2025.
Al-Sawaf O, Stumpf J, Zhang C, et al. Fixed-duration versus continuous targeted treatment for previously untreated chronic lymphocytic leukemia: Results from the randomized CLL17 trial. Abstract 2071 presented at the American Society of Hematology Congress, 2025. Orlando, Florida. 
Voorhees P, D'Souza A, Quach H, et al. Etentamig plus pomalidomide-dexamethasone combination therapy in relapsed or refractory multiple myeloma: A phase 1b dose-escalation and safety expansion study. Abstract 1875 presented at the American Society of Hematology Congress, 2025. Orlando, Florida. 
Daver N, Advani A, De La Fuente Burguera A, et al. Efficacy and safety of pivekimab sunirine in combination with venetoclax plus azacitidine in unfit patients with newly diagnosed Acute Myeloid Leukemia. Abstract 2524 presented at the American Society of Hematology Congress, 2025. Orlando, Florida. 
Cazzato G, Capuzzolo M, Bellitti E, et al. Blastic Plasmocytoid Dendritic Cell Neoplasm (BPDCN): Clinical Features and Histopathology with a Therapeutic Overview. Hematol Rep 2023;15(4):696-706 doi: 10.3390/hematolrep15040070.

Contacts:

SOURCE AbbVie Inc.
2025-12-02 13:21 4mo ago
2025-12-02 08:15 4mo ago
MiMedia Provides Business Update Heading into Calendar Year-End stocknewsapi
MIMDF
All Partners Shipping Devices with MiMedia Integrated at Same Time New York, New York--(Newsfile Corp. - December 2, 2025) - MiMedia Holdings Ltd. (TSXV: MIM) (OTCQB: MIMDF) (FSE: KH3) ("MiMedia", "Company"), is pleased to provide a brief business update heading toward the end of the 2025 calendar year.
2025-12-02 13:21 4mo ago
2025-12-02 08:15 4mo ago
BrandPilot AI Expands Customer Portfolio stocknewsapi
BPAIF
Leading Global Brands Across Retail, Telecom, Financial Services and Non-Profit Sectors Choose BrandPilot AI
December 02, 2025 8:15 AM EST | Source: BrandPilot AI Inc.
Toronto, Ontario--(Newsfile Corp. - December 2, 2025) -  BrandPilot AI Inc. (CSE: BPAI) (OTCQB: BPAIF) ("BrandPilot" or the "Company"), a leading innovator in AI-powered marketing and advertising technology, is pleased to announce the continued expansion of its customer portfolio, welcoming a diverse group of new customers across industries including retail, telecommunications, financial services, beauty, and non-profit.

In recent months, BrandPilot has onboarded several top-tier North American and global organizations who are now leveraging the Company's core offering to reduce media waste, increase efficiency, and unlock untapped budget within their digital advertising programs. This sustained momentum underscores BrandPilot's growing reputation as a trusted performance partner for enterprise brands seeking to optimize spend, improve ROI, and make data-driven decisions in an increasingly complex advertising landscape.

Customer Success Highlights

Leading North American Telecom Provider

Within the first 29 days of using AdAi across two major regions, this telecom organization achieved more than 58,000 optimized clicks and reduced its cost-per-click (CPC) by 78-79%. The program identified approximately $28,000 in monthly savings, enabling over $21,000 in potential reinvestment toward digital growth initiatives.

National Financial Services Firm

In the first 13 days post-activation, this financial services leader generated 7,146 AdAi-driven clicks, representing 91% of total campaign traffic. CPC dropped by 80%, from $0.26 to $0.05, resulting in $871 in immediate savings and more than $2,000 in projected monthly efficiencies.

Global Beauty & Personal Care Brand

Over the first 26 days, this beauty brand recorded 15,768 clicks, representing 81% of all campaign traffic, while reducing CPC by 66%. The campaign delivered $3,599 in immediate savings and an estimated $4,200 in ongoing monthly cost reduction.

International Non-Profit Organization

After launching in early September, this mission-driven organization secured 1,606 optimized clicks and reduced CPC by 55% within the first 12 days. The initiative generated $530 in early savings, with more than $1,300 in projected monthly efficiency available for reinvestment into outreach programs.

Revenue Expansion Through Progressive Adoption

Early monthly revenue figures will often be modest on a per-customer basis as engagements typically begin with a narrow diagnostic scope-focused on a limited number of branded keywords or pilot segments. As customers validate that there is no drop in click-throughs, traffic quality, or revenue-and often an increase in efficiency and conversion consistency-they expand coverage steadily. This expansion, combined with our variable-fee model tied to a portion of verified savings, causes revenue per customer to grow meaningfully over time. In many cases, we expect that revenue from a customer in month six will be several multiples of the initial first-month contribution.

"Our revenue model is simple-we only earn when we deliver verified savings. Customers start with small tests, but once they see stable performance and real cost reductions, they expand quickly, and that growth compounds our revenue over time. The steady increase in our customer base, paired with strong post-audit adoption, shows our growing position in enterprise performance marketing. Because our fees scale directly with validated savings, each engagement becomes a long-term compounding opportunity. As more organizations move from evaluation to activation, we expect recurring revenue per customer to rise through broader keyword coverage, higher optimization volumes, and deeper integration into their digital workflows." said John Beresford, Chief Revenue Officer at BrandPilot AI.

Continued Growth in Platform Demand

BrandPilot's commercial pipeline also continues to accelerate. As previously disclosed, the Company's evaluation cohort included 43 organizations actively assessing AdAi; this group has now expanded to more than 65 companies across North America, Europe, and APAC, representing substantial category diversity and growing global interest in BrandPilot's technology. In addition, the Company has initiated a significant number of formal audits over the past 60 days, reflecting heightened demand from enterprise brands seeking independent verification of media waste, efficiency gaps, and savings opportunities within their advertising programs.

New Customers Advancing Into Live Trials

In addition to the expanding evaluation pipeline, two organizations-a national home furnishings retailer and a fast-growing education technology company-have recently advanced from preliminary assessment into full live trials of the AdAi solution. These transitions reflect the strength of early diagnostic findings and the clear financial upside identified during initial evaluations. Both companies are now running active campaigns through AdAi, further validating the platform's ability to uncover measurable efficiency gains across diverse industry sectors.

Across BrandPilot's commercial pipeline, a significant percentage of organizations that complete an AdAi audit transition into an active trial or full deployment. Over the past 60 days, the Company has seen one of its highest conversion periods to date, with a growing portion of evaluated keywords being added into managed campaigns each week. In many cases, clients initially test fewer than 25 keywords, but quickly scale to hundreds or thousands as efficiency gains are validated and internal teams gain confidence in AdAi's automation.

About BrandPilot AI

BrandPilot AI (CSE: BPAI) is a performance marketing technology company headquartered in Toronto, specializing in innovative solutions that deliver exceptional ROI for global enterprise brands. Its core platform, AdAi, identifies hidden inefficiencies in digital advertising campaigns and helps brands recover wasted ad spend in real time. Additional products, including Spectrum IQ and Social Runway, support AI-powered influencer marketing and paid social performance.

CONTACT INFORMATION
BrandPilot AI
Brandon Mina
Chief Executive Officer
+1-888-960-2724
[email protected]

Forward Looking Statements

This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the business of BPAI. Any such forward-looking statements may be identified by words such as "expects", "anticipates", "believes", "projects", "plans" and similar expressions. Readers are cautioned not to place undue reliance on forward-looking statements. Statements about, among other things, BPAI's strategic plans, including words to the effect that the Company or management expects a stated condition or result to occur, are all considered forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. BPAI assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

Forward-looking statements involve significant risk, uncertainties and assumptions. Many factors could cause actual results, performance or achievements to differ materially from the results discussed or implied in the forward-looking statements. These risks and uncertainties include, but are not limited to: the rate of adoption of AdAi for Google Shopping Ads, the performance and effectiveness of the AdAi platform in reducing wasted spend and improving ROAS, the growth and size of the retail search advertising market, changes to Google's advertising products or policies, competitive pressures in AI-powered marketing solutions, and the Company's ability to achieve its proposed business objectives. These factors should be considered carefully and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management believes to be reasonable assumptions, the Company cannot assure readers that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this news release, and the Company assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law.

Neither the Canadian Securities Exchange, nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276616
2025-12-02 13:21 4mo ago
2025-12-02 08:16 4mo ago
Can Enterprise Products Withstand the Pressure of Soft Crude Prices? stocknewsapi
EPD
Key Takeaways EPD says fee-based earnings remained its largest gross operating margin contributor in recent years.Midstream assets booked long-term help Enterprise Products maintain predictable cash flows.EPD units gained 4.7% over the past year while trading slightly below the industry's EV/EBITDA average.
With West Texas Intermediate (WTI) oil prices currently trading below $60 per barrel, according to data from Oilprice.com, which is significantly lower than a year ago, the overall energy business is now highly uncertain. However, Enterprise Products Partners LP (EPD - Free Report) , a midstream energy major, is not highly vulnerable to the volatility in commodity prices.

This is because midstream assets are usually backed by stable fee-based revenues since the pipeline and storage assets are booked by shippers for a long term. Notably, EPD’s midstream properties comprise pipeline assets spanning more than 50,000 miles, liquids storage properties with a capacity of more than 300 thousand barrels and other assets.

Enterprise Products Partners noted that fee-based earnings have consistently been the largest contributor to its gross operating margin each year. The partnership noted that fee-based earnings contributed 82% in 2021, 74% in 2022, 77% in 2023, 78% in 2024 and 82% in the first nine months of this year. Thus, it can be concluded that Enterprise Products’ business model is highly predictable and hence stable.

KMI & ENB Also Have Stable Business ModelsKinder Morgan Inc. (KMI - Free Report) and Enbridge Inc. (ENB - Free Report) are two other midstream energy majors. By the very nature of their businesses, both KMI and ENB also have predictable cash flows. This is because KMI and ENB also generate stable fee-based earnings from their respective midstream assets.

As of the September quarter of 2025, KMI’s project backlog was $9.3 billion. ENB, on the other hand, mentioned that it has secured a capital program of C$35 billion. Thus, both Kinder Morgan and Enbridge have gained additional cash flows.

EPD’s Price Performance, Valuation & EstimatesUnits of EPD have gained 4.7% over the past year against the 8.2% decline of the composite stocks belonging to the industry.

Image Source: Zacks Investment Research

From a valuation standpoint, EPD trades at a trailing 12-month enterprise value to EBITDA (EV/EBITDA) of 10.59X. This is below the broader industry average of 10.60X.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for EPD’s 2025 earnings has seen downward revisions over the past seven days.

Image Source: Zacks Investment Research

Enterprise Products currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
2025-12-02 13:21 4mo ago
2025-12-02 08:16 4mo ago
Uber's Radical Turnaround: From Cash Burner To Cash Engine stocknewsapi
UBER
HomeStock IdeasLong IdeasIndustrial 

SummaryUBER has transformed from a cash-burning startup to a highly profitable, cash-generating enterprise, justifying a strong Buy rating.
UBER’s aggressive expansion into delivery, AI, and autonomous vehicles, including partnerships with NVIDIA and investments in robotaxi startups, underpins its future growth trajectory.
UBER’s financial turnaround is evident: $49.6B revenue (+18.25% YoY), $16B TTM net income (33.54% margin), and $6.7B levered FCF (13.68% margin).
Despite a C+ valuation grade, UBER’s forward P/E of 13.59 suggests undervaluation, with a potential price target up to $109, implying major upside.
MOZCO Mateusz Szymanski/iStock Editorial via Getty Images

Invest Thesis Despite its reputation as a cash burner, I am bullish on UBER Technologies (UBER) given its recent transformation into a company that can generate substantial cash. This marks a clear

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Quick Insights

Recommended For You
2025-12-02 13:21 4mo ago
2025-12-02 08:17 4mo ago
MILLER INDUSTRIES ANNOUNCES ACQUISITION OF OMARS stocknewsapi
MLR
, /PRNewswire/ -- Miller Industries, Inc. (NYSE: MLR) ("Miller Industries" or the "Company"), the World's Largest Manufacturer of Towing and Recovery Equipment, today announced that it has completed the acquisition of Omars – S.p.A ("Omars"), a designer and manufacturer of towing and recovery vehicles, in an all-cash transaction for an aggregate purchase price of approximately €17.5 million, or $20.3 million, subject to certain pre- and post-closing adjustments for cash and net working capital.

Omars, headquartered in Cuneo, Italy, has over 45 years of experience in manufacturing light-duty, medium-duty and heavy-duty car carriers and recovery vehicles. With a highly complementary product portfolio, this acquisition expands Miller Industries' footprint in the European market with an additional well-recognized European brand, providing opportunities for Miller Industries to increase market share in the region. This acquisition will provide Miller Industries with additional capacity which the Company expects will improve its manufacturing flexibility and its ability to meet growing customer demands. Omars' annual revenue for 2024 was approximately $27 million and the transaction is expected to be accretive in year one.

Chief Executive Officer, William G. Miller II, stated, "This acquisition is a milestone in our plans to expand our footprint in current and new global markets. As we continue to deploy our capital allocation strategy, we remain open to global growth opportunities, while continuing to return capital directly to our shareholders through our quarterly dividend and our share repurchase program. Omars is a strong strategic fit for Miller Industries. With its modern manufacturing facility, strong sales team, and experienced senior staff, we anticipate that the Omars acquisition will provide benefits to both our top-line growth and our profitability."

Mr. Miller II, concluded, "Omars has a reputation of providing its customers with high quality and reliable products across all platforms. The combination of our existing global engineering and manufacturing resources with those of Omars will prove incredibly valuable as we look to expand throughout Europe. We look forward to working with the entire Omars team to provide a world class experience for all of our existing Miller Industries and Omars customers."

Certain statements in this news release may be deemed to be forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of words such as "may", "will", "should", "could", "continue", "future", "potential", "believe", "project", "plan", "intend", "seek", "estimate", "predict", "expect", "anticipate" and similar expressions, or the negative of such terms, or other comparable terminology and include without limitation any statements relating to the impact and success of the Company's acquisition of Omars, including statements relating to the Company's top-line growth and profitability, as well as the Company's manufacturing capacity and plans to expand throughout Europe. Forward-looking statements also include the assumptions underlying or relating to any of the foregoing statements. Such forward-looking statements are made based on our management's beliefs as well as assumptions made by, and information currently available to, our management. Our actual results may differ materially from the results anticipated in these forward-looking statements due to, among other things: our dependence upon outside suppliers for component parts, chassis and raw materials, including aluminum, steel, and petroleum-related products leaves us subject to changes in price and availability, the cadence and quantity of deliveries from our suppliers, and delays in receiving supplies of such materials, component parts or chassis; our customers' and towing operators' access to capital and credit to fund purchases; the implementation of new or increased tariffs and any resulting trade wars and any resulting macroeconomic uncertainty; the rising costs of equipment ownership, including continuing increases in insurance premiums and elevated interest rates that have added cost pressures to our end users, and fluctuations in the value of used trucks; macroeconomic trends, availability of financing, and changing interest rates; our customers' ability to fund purchases of our products increases in the cost of skilled labor; the cyclical nature of our industry and changes in consumer confidence and in economic conditions in general; special risks from our sales to U.S. and other governmental entities through prime contractors; changes in fuel and other transportation costs, insurance costs and weather conditions; changes in government regulations, including environmental and health and safety regulations; failure to comply with domestic and foreign anti-corruption laws; competition in our industry and our ability to attract or retain customers; our ability to develop or acquire proprietary products and technology; assertions against us relating to intellectual property rights; changes in the tax regimes and related government policies and regulations in the countries in which we operate; the effects of regulations relating to conflict minerals; the catastrophic loss of one of our manufacturing facilities; environmental and health and safety liabilities and requirements; loss of the services of our key executives; product warranty or product liability claims in excess of our insurance coverage; potential recalls of components or parts manufactured for us by suppliers or potential recalls of defective products; an inability to acquire insurance at commercially reasonable rates; a disruption in, or breach in security of, our information technology systems or any violation of data protection laws; and those other risks discussed in our filings with the Securities and Exchange Commission, including those risks discussed under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024 and subsequent Quarterly Reports on Form 10-Q, which discussion is incorporated herein by this reference. Such factors are not exclusive. We do not undertake to update any forward-looking statement that may be made from time to time by, or on behalf of, the Company.

SOURCE Miller Industries, Inc.
2025-12-02 13:21 4mo ago
2025-12-02 08:17 4mo ago
Worksport Achieves Historic Online Sales Milestone With Record Black Friday Performance stocknewsapi
WKSP
400% YoY Increase; Direct-to-consumer e-commerce single day sales exceed $200,000 and weekly sales reach $665,000 WEST SENECA, NY / ACCESS Newswire / December 2, 2025 / Worksport Ltd. (NASDAQ:WKSP) ("Worksport" or the "Company"), a U.S.-based innovator in advanced manufacturing, clean energy technologies and automotive accessories, serving both consumer and reseller markets, today announced that November 28, 2025, marked the highest single day of online sales in its history.